APPI News — Health

US and European guidelines put CBT-I first for chronic insomnia

APPI News Editorial — Sat, 15 Aug 2026 12:00:00 GMT

A 2025 clinical guideline from the US Departments of Veterans Affairs and Defense strongly recommends cognitive behavioral therapy for insomnia (CBT-I) for chronic insomnia disorder and weakly favors it over medication as first-line care. The 2023 European insomnia guideline also recommends CBT-I first for adults of any age, including those with other medical or psychiatric conditions.

CBT-I is a structured treatment rather than another name for sleep hygiene. It combines changes to sleep timing and bed use with cognitive work, relaxation and sleep education; the European guideline says medication can be offered when CBT-I is not sufficiently effective.

Urgent mental-health symptoms take priority over insomnia treatment

England's National Health Service (NHS) says hallucinations require medical help and calls for emergency care when a person wants to harm themselves or someone else, hears voices directing harm, becomes very agitated, has rapidly worsening hallucinations or suddenly becomes confused. In other countries, the local emergency number or nearest emergency department is the appropriate route.

The 2025 US guideline says CBT-I may need to be delayed for current suicidal ideation or acute mental-health symptoms. A routine insomnia program should wait until immediate safety and acute symptoms have been assessed.

Chronic insomnia is a diagnosis, not a run of bad nights

The 2025 US guideline defines chronic insomnia disorder as sleep difficulty at least three times a week for more than three months, with daytime consequences despite an adequate opportunity to sleep. It also says diagnosis requires a clinical evaluation rather than a questionnaire score alone.

The European guideline calls for a clinical interview covering sleep and medical history, supported by sleep diaries and questionnaires, with a physical examination and other measures when indicated. It reserves overnight sleep testing for suspected additional sleep disorders, treatment-resistant insomnia or other clinical indications rather than routine evaluation.

CBT-I combines five forms of work

In 2023, the World Sleep Society endorsed multicomponent CBT-I as the treatment of choice for chronic insomnia in adults and conditionally endorsed stimulus control, sleep restriction and relaxation as separate therapies. The endorsement did not support sleep-hygiene education as a treatment on its own because evidence for that use was insufficient.

Stimulus control strengthens the bed as a cue for sleep rather than wakefulness and establishes consistent sleep patterns. Sleep restriction therapy initially limits time in bed to actual sleep duration and extends it as sleep efficiency improves.

Cognitive restructuring addresses racing thoughts and inaccurate beliefs about sleep by challenging unhelpful thoughts. Relaxation or counter-arousal strategies reduce physical activation, while sleep-hygiene education addresses light, noise, eating, caffeine, nicotine and alcohol around bedtime.

The five elements are adjusted as a package rather than applied as a fixed checklist. The 2025 US guideline describes CBT-I as a multi-session treatment and says sleep diaries help providers estimate and adjust a sleep schedule. The World Sleep Society did not endorse sleep-hygiene education as a treatment on its own.

Comparative evidence favors starting with CBT-I, with limits

A 2024 systematic review and network meta-analysis combined 13 trials involving 823 randomized adults who were not taking hypnotic medicines when enrolled. At a median follow-up of 24 weeks, the odds of remission were higher after starting with CBT-I than after starting with pharmacotherapy, with an odds ratio of 1.82 and a 95 percent confidence interval of 1.15 to 2.87.

The review estimated long-term remission in 41 percent of participants starting with CBT-I and 28 percent starting with pharmacotherapy. Those figures describe the included trials, not a guaranteed outcome, and they do not compare every medicine, treatment combination or patient group.

The 2025 US guideline grades its overall recommendation for CBT-I as strong, but its preference for CBT-I over medication as first-line treatment is weak. The recommendations establish a treatment sequence for clinicians; they do not determine whether an individual prescription should change.

Sleep restriction can temporarily worsen daytime function

The 2025 US guideline reports temporary sleepiness from the sleep-restriction component and says trained professionals should deliver CBT-I to reduce related risks. England's NHS advises people not to drive when sleepy, and the same safety concern applies to other tasks in which reduced alertness could cause harm.

The US guideline lists unstable medical conditions, excessive daytime sleepiness, nighttime fall risk, uncontrolled seizure disorders, bipolar disorder, pregnancy or postpartum insomnia, and acute mental-health symptoms as reasons to adapt or delay CBT-I. These factors do not rule out treatment in every case, but they require an individualized plan.

The World Sleep Society endorsement concerns adults with chronic insomnia, so it does not establish an adult sleep-restriction schedule for children or adolescents. Pediatric sleep problems require a separate clinical assessment rather than a copied adult protocol.

England's NHS notes that many medicines can contribute to insomnia and advises checking with a doctor before taking a sleep aid. Regular prescriptions and nonprescription products should be reviewed with a clinician or pharmacist before any sleep-related medicine change, while availability and regulatory status vary by country.

Delivery can be in person or digital, but access is uneven

The European guideline recommends either in-person or digital CBT-I. The World Sleep Society says individual, in-person CBT-I from a trained professional remains the optimal delivery method while provider training and access vary internationally.

Primary care services, sleep clinics and qualified mental-health professionals may be able to assess local options. APPI News could not verify a single global credential or provider directory at the time of writing, so credentials and referral routes need to be checked in the country where care is delivered.

A positive FIT result prompts colonoscopy, not a cancer diagnosis

APPI News Editorial — Fri, 14 Aug 2026 12:00:00 GMT

A positive fecal immunochemical test (FIT) means a laboratory detected blood in a stool sample; it does not diagnose colorectal cancer. The result starts a diagnostic pathway because FIT cannot show where the bleeding came from.

Someone who receives a positive screening result should contact the program or clinician that ordered the test so follow-up can be arranged. Colonoscopy can inspect the colon directly, remove polyps and take tissue for pathology; another stool sample cannot perform any of those tasks.

Symptoms need assessment rather than routine screening

Screening is designed for people without symptoms. The World Health Organization lists blood in the stool, a change in bowel habits, persistent abdominal pain or bloating, unexplained weight loss, fatigue and iron-deficiency anemia as possible colorectal cancer symptoms.

These signs have many noncancer causes, but they warrant clinical assessment rather than waiting for the next screening invitation. The UK National Health Service advises urgent assessment for black or dark-red stool or bloody diarrhea, and emergency help for nonstop or heavy rectal bleeding, such as large clots or toilet water turning red.

Readers outside the United Kingdom should use local urgent-care or emergency services. A previous negative FIT should not delay assessment when symptoms are present.

A positive result means blood crossed the test cutoff

FIT measures hemoglobin, a blood protein, in a small stool sample. The International Agency for Research on Cancer (IARC) says available FITs have wide ranges of sensitivity and specificity, and that the balance of benefits and harms depends on the cutoff used for a positive result.

A positive result identifies blood, not its source. Australia's national screening program says a positive result does not always mean bowel cancer, that many causes of blood are unrelated to cancer, and that the usual next step is referral for colonoscopy.

The chance of finding cancer cannot be carried from one program to another without context. NHS England reports bowel cancer in seven to 10 of every 100 people who undergo colonoscopy after an abnormal screening result and says its figures are only a general guide, not a personal risk estimate. APPI News did not repeat the source article's 5 percent estimate as a worldwide figure because no international dataset matching that claim was identified.

Colonoscopy completes the positive FIT pathway

IARC found sufficient evidence that screening every two years with FIT, when coupled with colonoscopy after a positive result, reduces colorectal cancer mortality; the reviewed studies reported risk reductions from 10 percent to 40 percent. The evaluation assumes high-quality testing and adequate follow-up, and most of the evidence came from asymptomatic, average-risk populations in middle- or high-income settings.

During colonoscopy, a clinician examines the colon with a camera, can remove polyps and can take a biopsy when tissue needs laboratory testing. These functions allow the procedure to distinguish among findings that a blood test cannot separate.

Colonoscopy also requires bowel cleansing and may involve sedation. England's screening information lists rare risks including a reaction to sedation, heavy bleeding, bowel perforation and a missed lesion; suitability and personal risk depend on health and procedure details.

Because bleeding can be intermittent, a later negative sample cannot by itself resolve an earlier positive result. Australia's program explains that some bowel cancers do not bleed or bleed only sometimes, and directs people with a positive result to seek assessment of the bleeding source.

Screening ages and intervals depend on the country

The fifth European Code Against Cancer recommends quantitative FIT every two years for people aged 50 to 74. The US Preventive Services Task Force recommends screening average-risk adults from ages 45 to 75 and lists annual FIT as one option, with selective screening from ages 76 to 85.

Those frameworks apply to specified populations and are not global clinical or coverage rules. Invitation ages, FIT cutoffs, sample procedures, payment and access to follow-up colonoscopy vary by country, so the schedule should come from the program or guideline used where the reader receives care.

The routine interval applies after a negative screening result, not after a positive one. A positive FIT moves the person into a diagnostic pathway even if the next routine invitation would otherwise be one or two years away.

Higher-risk and special populations need a separate plan

The schedules above describe asymptomatic adults at average risk. The World Health Organization identifies family history, inherited syndromes, previous colorectal cancer and certain polyps as risk factors, and says people with a family history or inherited syndrome may need genetic counseling and tailored screening.

The population-screening guidance cited here does not include children and does not establish a single approach during pregnancy. A child or pregnant person with rectal bleeding or a change in bowel habits should receive clinician-led assessment rather than apply an adult home-screening interval; APPI News could not find one international FIT schedule for either group.

Major chronic illness and regular medicines can also affect whether and how colonoscopy is performed. England's program checks health conditions and medicines before colonoscopy and may consider computed tomography colonography when colonoscopy is unsuitable. Any medicine changes should follow instructions from the procedure team.

Positive, negative and inconclusive results lead to different steps

After a positive result, contact the ordering program or clinician and ask how diagnostic follow-up is arranged. If cost, transport, time off work or colonoscopy access creates a barrier, tell the service coordinating the screening rather than treating a second FIT as clearance.

After a negative result, return at the interval set by the local program, but seek assessment if symptoms develop between rounds. An inconclusive result is different: the laboratory could not analyze the sample, so the program may issue a replacement kit and new collection instructions.

Frequently asked questions

Does a positive FIT mean colorectal cancer?
No. It means blood was detected above the test's cutoff, and colonoscopy is used to identify the cause.

Can a second FIT clear a positive result?
No. A later negative result cannot locate the earlier bleeding source, and intermittent bleeding means it cannot rule out colorectal cancer.

Does a negative FIT rule out colorectal cancer?
No. Some cancers do not bleed continuously, and symptoms should be assessed even after a recent negative screening result.

At what age should FIT screening start?
There is no single worldwide starting age or interval. The European and US examples in this guide differ, and local programs may use other eligibility rules.

Should someone with symptoms wait for a screening invitation?
No. Screening schedules are for people without symptoms; blood in stool, persistent bowel changes, unexplained weight loss or lasting abdominal pain warrants clinical assessment.

Five checks separate health-product claims from usable evidence

APPI News Editorial — Thu, 13 Aug 2026 12:00:00 GMT

An April 2026 BMJ Open audit rated 49.6 percent of 250 responses from five consumer chatbots as problematic when tested with misinformation-prone health prompts. Consumers can reduce that risk by checking the exact claim against regulator records, matching it to human evidence and opening every cited source.

A usable check has five parts: capture what the seller actually promises, identify the regulator for the market where the product is sold, trace the evidence to its full source, search for missing or contrary information, and verify any leads supplied by artificial intelligence (AI). No approval mark, product register or advertising rule applies worldwide, so the country and product category belong at the start of the check.

Urgent symptoms come before claim checking

The United Kingdom National Health Service lists sudden swelling of the lips, mouth, throat or tongue, trouble breathing or swallowing, sudden confusion and fainting as possible signs of anaphylaxis. If any of these symptoms begin after a food, supplement or other health product, call the local emergency service immediately instead of spending time investigating the advertisement.

Pregnancy and breastfeeding

The US National Center for Complementary and Integrative Health says many supplements have not been tested in pregnant or breastfeeding people. Evidence from other adults cannot establish safety in pregnancy or breastfeeding, so a clinician should assess the exact product before use.

Children

The same US guidance says many supplements have not been tested in children. Adult studies and label instructions cannot establish pediatric safety, so a clinician or pharmacist should assess the exact ingredients and intended use.

Chronic conditions, surgery and regular medicines

The US center says supplements may interact with medicines, pose added risks with some medical conditions or affect surgery. People in these groups should give a clinician or pharmacist the full product label and a list of regular medicines before use.

Step one: write down the claim before checking it

Save the exact words, images and context rather than reducing an advertisement to a vague phrase such as “good for immunity.” The US Federal Trade Commission's 2022 guidance says an advertisement's overall message can include express statements, product names, pictures, graphs and implied claims. That is a rule for US advertising, but the recording method prevents a seller's visual or indirect promise from disappearing during a fact-check.

Record the product name, manufacturer, full formulation, route, amount, advertised population, promised outcome, time frame, country of sale and date viewed. A study cannot support a claim until its tested product and outcome match those details.

Disease words also change the regulatory question. The US Food and Drug Administration says a product intended to treat, diagnose, cure or prevent disease is a drug even if its label calls it a dietary supplement, while the agency does not approve dietary supplements for safety and effectiveness before they reach the US market. This distinction is specific to the United States; it is not a shortcut for deciding how another country classifies the same product.

Step two: find the regulator and read what its record means

Start with the authority responsible for that product category in the place where it is sold. Search the exact product or claim, then compare the manufacturer or sponsor, ingredients, record number, status and date with the package. A number printed on a label is not verified until those details match the official record.

Registers answer different questions. The European Commission says its public register lists permitted nutrition claims and both authorized and non-authorized health claims for foods in the European Union. It is a claims register, not proof that every food bearing an allowed phrase has been tested as a finished product.

Australia's Therapeutic Goods Administration says all medicines supplied in Australia must appear in the Australian Register of Therapeutic Goods, but AUST L medicines are listed without a premarket efficacy assessment while AUST L(A) and AUST R products receive one. A register entry therefore needs to be read with its category and assessment route rather than treated as a universal efficacy certificate.

The US, European Union and Australian examples are not a complete global directory. If the seller does not identify the country where a registration or claim is valid, ask for the authority's full name and a direct record link. APPI News could not verify the corresponding databases and claim rules in every market at the time of writing.

Step three: trace “research-backed” to the full source

The US National Institutes of Health Office of Dietary Supplements advises checking who runs and funds a health website, its purpose, its original sources, the credentials of its reviewers and when the information was updated. The same guide says medical facts should carry retrievable references and that testimonials are not evidence-based.

A citation should lead to the full paper or an official report, not only a press release, sales page, influencer post or abstract. Confirm the title, authors, journal, year and digital object identifier, then check whether the linked source makes the claim attributed to it. Read the funding and conflict-of-interest declarations before weighing the result.

The evidence must match the finished product, route, amount, population, comparison, duration and outcome in the advertisement. A cell experiment cannot establish a benefit in people, an animal experiment cannot establish a consumer outcome, and a study of one ingredient cannot automatically support a mixture with different ingredients.

The US Federal Trade Commission generally treats randomized controlled human trials as the most reliable support for health-benefit claims, says independent replication adds weight and warns that research quality matters more than the number of weak studies. Its guidance also distinguishes an observational association from evidence of causation and calls for the whole body of relevant evidence to be considered.

Step four: look for evidence a sales page leaves out

A favorable paper is one part of a research record. Search for systematic reviews, later trials, corrections, retractions, adverse-event reports and regulator warnings using the same ingredient and product terms. Look for null or harmful findings, not only papers cited by the seller.

Cochrane describes systematic reviews as a structured examination of all research that meets predefined criteria for a question, making them more reliable than an individual study for assessing whether an intervention or test works. A review still needs to match the product and outcome, and uncertainty in its findings cannot be converted into a positive marketing claim.

For a clinical trial, search a registry by title, investigator, intervention and registration number. The World Health Organization says prospective registration helps reveal publication bias and selective reporting and directs users to primary registries in its registry network. A registry record shows what researchers planned; it does not show that a trial was completed or that the result favored the product.

Compare the registered primary outcome, enrollment target and time frame with the published report. A changed outcome, smaller sample or missing result needs an explanation, while a matching record improves transparency without proving that the study was unbiased.

Step five: use AI for leads, then verify every source

The BMJ Open audit tested free versions of Gemini, DeepSeek, Meta AI, ChatGPT and Grok in February 2025. Researchers used 50 prompts across cancer, vaccines, stem cells, nutrition and athletic performance for each chatbot, producing 250 responses. The prompts were designed to push the systems toward misinformation or contraindicated advice, so the study tested a demanding scenario rather than every routine health question.

The researchers rated 30 percent of responses somewhat problematic and 19.6 percent highly problematic, found a median reference-completeness score of 40 percent and reported that fabricated citations prevented every chatbot from producing a fully accurate reference list. Those results apply to the named versions and test design; they do not rank current models, which can change after release.

AI can still organize the exact claim, generate neutral search terms and suggest a regulator, trial registry or paper to inspect. Open each suggested page independently and confirm its title, authors, date, identifier and conclusion. A plausible citation that cannot be found, or a real paper that does not support the sentence, should be treated as a failed check.

A short record makes the check reproducible

Keep the original claim and screenshot, the market and product category, the regulator record, the strongest matching human evidence and any safety warning or unresolved gap. Add the date of the check because advertisements, database entries, warnings and AI systems can change.

The result does not have to be a simple “true” or “false.” “Authorized wording in one market,” “supported only for a different formulation,” “one small trial with no independent replication” and “no matching source found” are more precise findings, and they preserve the limits of what was actually verified.

Frequently asked questions

Does a regulator number prove that a health product works?
No. Its meaning depends on the jurisdiction, product category and assessment route. Check the official record for what was reviewed and whether it covers efficacy, legal supply, manufacturing, an ingredient or only specified claim wording.

Does publication in a journal prove a marketing claim?
No. Publication does not by itself establish that the study was well designed or that it tested the same formulation, route, population and outcome. Read the full methods and results, then look for independent studies and systematic reviews.

Are cell and animal studies useless?
No. They can identify mechanisms and support further research, but they do not establish that a consumer product produces a health benefit in people. A human-benefit claim needs evidence measuring that outcome in an appropriate human population.

Can an AI chatbot complete the five checks?
It can propose search terms and possible sources, but every citation and claim still needs manual verification. The 2026 audit found poor reference completeness and fabricated citations even when answers were written confidently.

Who can help when the evidence or safety question remains unclear?
The regulator responsible for the product in the country of sale can clarify records, warnings and reporting routes. A clinician or pharmacist can assess personal factors such as pregnancy, childhood, chronic conditions, surgery and medicine interactions.

WHO's ICOPE pathway puts follow-up after six-area screening

APPI News Editorial — Thu, 13 Aug 2026 00:00:00 GMT

The World Health Organization published its second-edition Integrated Care for Older People handbook on September 22, 2025. The guidance places a basic assessment of six areas at the start of a pathway that continues through in-depth assessment, a personalized care plan, and implementation and monitoring.

The sequence defines the screen's limited role: it identifies possible loss of capacity rather than a disease. A result in one area does not explain its cause, and an unflagged result does not rule out every functional problem.

The screen covers six parts of daily capacity

Integrated Care for Older People (ICOPE) organizes intrinsic capacity into cognition, mobility, vitality, vision, hearing and psychological capacity. WHO sometimes groups vision and hearing together as one sensory domain, which is why technical papers may refer to five domains while public-facing material lists six areas.

The screen uses short questions and tasks to look for possible changes in those areas. Vitality includes appetite and unintentional weight loss, while psychological capacity includes low mood and loss of interest. These observations concern function in daily life; they do not name the condition behind a change.

Assessment and monitoring follow the initial result

The 2025 handbook sets out four stages: basic assessment, in-depth assessment, development of a personalized care plan, and implementation and monitoring. It also says the care pathways must be adapted to local conditions, including the available health and social care services.

WHO's 2017 guidelines put older adults' needs and preferences at the center of care and call for coordination across services. Counting completed screens therefore measures reach, but it does not show whether flagged results led to assessment, support or continued monitoring.

WHO pilots tested readiness across different health systems

WHO's implementation pilot developed country case studies with partners in Andorra, China, France and India, and all four provided ICOPE screening to older participants. The program also received responses from 260 health and care workers in 29 nominated member states and 259 service- and system-level respondents in 35 nominated member states.

Those surveys examined feasibility, coordination and system readiness. They were not multinational trials of whether the screen itself preserved function, and they did not establish one referral model for every country.

A Spanish study found uneven performance by domain

A 2023 cross-sectional study compared the ICOPE screen with detailed reference assessments in 207 community-dwelling adults aged 70 or older from five rural and urban areas of Catalonia, Spain. The participants had a high degree of independence, and the researchers used a convenience sample.

Sensitivity was 88.9 percent for cognition but ranged from 43.8 to 56.9 percent for most other domains. Specificity ranged from 68.2 to 96 percent. The screen flagged at least one area in 70 percent of participants, compared with 79 percent under the detailed reference assessments.

The researchers described the overall performance as fair and recommended external validation in other populations. Their results show why the same screen can miss some changes while flagging others that a fuller assessment does not confirm.

Taiwan's adapted version produced a different evidence set

Taiwan's locally adapted questionnaire, the Integrated Care for Older People Screening Tool for Taiwanese (ICOPES-TW), covers the WHO capacity domains and adds medication and life-goal items. That design is not interchangeable with every other ICOPE screen.

A 2024 study tested ICOPES-TW in 1,235 older adults recruited from community, outpatient and inpatient settings in southern Taiwan. The total score had moderate correlations with measures of daily activity, quality of life and frailty, but overall internal consistency was low, with a Cronbach's alpha of 0.55.

The researchers called the findings initial psychometric evidence. Their convenience sample was largely composed of relatively healthy participants, and the cross-sectional design could not establish prediction over time, test-retest reliability or responsiveness to change.

Screening evidence supports a narrow conclusion

The WHO pathway and the two validation studies support using a brief result as an entry point to fuller assessment. They do not show that one self-screen diagnoses disability, identifies the cause of a change or delays functional decline on its own.

For health systems, the four-stage sequence makes follow-through part of the intervention rather than an optional addition. Comparable data on referral completion and long-term functional outcomes under the second-edition pathway were not available across countries at the time of writing, so its impact cannot be summarized with one global rate.

Anti-aging labels stretch evidence for exosomes, NAD+ and peptides

APPI News Editorial — Wed, 12 Aug 2026 12:00:00 GMT

A July 2026 systematic review found only low- or very-low-certainty evidence for exosome-based nonsurgical facial rejuvenation after assessing 16 studies and 503 adults. The result shows the distance between an emerging research field and a broad anti-aging claim on a consumer product.

NAD+, stem cells and peptides create the same evidence problem in different ways. Each term names a molecule, cell type or chemical class, but none identifies a tested product, route, study population or health outcome. Those missing details determine whether published findings apply to what is being sold.

When an adverse reaction needs urgent care

The United Kingdom National Health Service says sudden swelling of the lips, mouth, tongue or throat, difficulty breathing or swallowing, fainting, or sudden confusion can signal anaphylaxis and may need immediate hospital treatment. Stop using the supplement and contact the local emergency service if these symptoms occur.

The US National Center for Complementary and Integrative Health advises people with side effects to stop taking the supplement and contact a clinician; it also says supplements can interact with medicines or create risks for some medical conditions, and many have not been tested in pregnancy, breastfeeding or children. A clinician or pharmacist needs the exact product label and medicine list to assess an individual risk.

A scientific term is not evidence for a finished product

A laboratory mechanism answers a narrow question, such as whether a molecule participates in cell signaling or whether a compound changes a blood marker. It does not establish that a packaged product slows aging in people. That claim requires a human comparison using the same ingredient, formulation and route, followed for a relevant outcome.

“Anti-aging” is not a single clinical measurement. Trials may record skin hydration, wrinkle scores, walking speed, blood chemistry or the incidence of a disease. A favorable result on one measure cannot be converted into a claim that a person is biologically younger or will live longer.

Exosome evidence remains early and route-specific

Exosomes are small extracellular vesicles released by cells and studied as carriers of biological material. The word identifies a research category, not a standardized consumer ingredient. Source cells, isolation methods, contents, storage and delivery can differ, so one preparation cannot stand in for every product using the term.

A July 2026 systematic review assessed 16 nonsurgical facial-rejuvenation studies with 503 adult participants and rated the certainty of effectiveness evidence as low or very low. Most studies reported an improvement in at least one skin measure, but risk of bias was moderate to critical for most effectiveness outcomes. Inconsistent measures, short follow-up and differences between interventions prevented firm conclusions.

Those preliminary findings do not establish a benefit for every capsule, cream, gel or injection labeled “exosome.” A seller would need evidence for the actual formulation and route rather than a paper about a different preparation. Short-term reports also cannot settle uncommon or delayed harms.

Regulatory conclusions are equally product- and country-specific. In May 2025, the US Food and Drug Administration told one seller that the exosome products described in its warning letter were unapproved new drugs and unlicensed biological products under US law. That action covers the cited products and claims; it does not determine the status of every exosome-related item in the United States or another country.

NAD+ target engagement does not prove slower aging

Nicotinamide adenine dinucleotide (NAD+) is involved in cellular metabolism. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) are precursors that the body can use in NAD-related pathways. Their biological role gives researchers a target to measure, but it does not establish a broad wellness outcome.

A 2026 systematic review identified 33 human intervention studies, including 28 randomized trials, and found that oral NR and NMN consistently changed circulating or cellular NAD-related markers. Functional, metabolic, vascular and other health-related outcomes were heterogeneous, often null or confined to particular endpoints. Human studies generally lasted weeks to months, leaving anti-aging effectiveness inconclusive.

The same review found no eligible outcome trials of intravenous or intramuscular NAD+ itself for anti-aging or wellness. Evidence from oral precursors therefore cannot be transferred to an infusion, and a rise in a blood marker cannot establish disease prevention, longer life or preserved independence.

A stem-cell label must identify what the product contains

A stem-cell treatment uses living stem cells or cells derived from them to replace or repair tissue. That is different from a consumer label that refers to stem cells without identifying the material, manufacturing process or route. Evidence for transplanted cells cannot support an oral or topical product with a different composition.

The International Society for Stem Cell Research said in its 2024 guide that stem-cell treatments must be evaluated for safety and efficacy in regulated clinical trials before national regulators approve them. The society also warned that some marketed interventions have not been shown to be safe or effective and, in some cases, have not even been shown to contain stem cells.

The words “stem cell” therefore do not establish identity, dose or performance. A credible claim needs a precise description of the material and a controlled human study of that same intervention for the advertised use.

Peptide and collagen claims require formulation-level evidence

“Peptide” describes a broad class of short amino-acid chains, not one intervention with a shared effect. Collagen peptides are one example, but results for a tested collagen formulation cannot prove a claim about an unrelated peptide. Digestion or detection of a peptide in blood addresses exposure rather than a visible or clinical outcome.

A 2025 meta-analysis assessed 23 randomized collagen trials with 1,474 participants and found that pooled results favored skin hydration, elasticity and wrinkles. The pattern changed when the authors separated the trials by funding and quality. Studies without pharmaceutical-company funding found no effect on those outcomes, and higher-quality studies also found no effect.

The authors concluded that current clinical evidence did not support collagen supplements for preventing or treating skin aging. That conclusion applies to the reviewed evidence and outcomes, not to every peptide product or every possible future formulation. It also shows why a favorable pooled number needs to be read alongside study quality and financial support.

Four details determine whether a claim matches the evidence

The first detail is identity. A report needs the exact ingredient, source, formulation and manufacturing description needed to match the commercial product with the studied intervention. An umbrella term such as exosome, peptide or stem cell is too broad for that match.

The second is route and exposure. Evidence from an injection does not establish an effect from a capsule or cream, while evidence from an oral precursor does not establish an infusion claim. The tested amount and duration also have to match, although no research dose in this report is a general recommendation.

The third is the human outcome. Animal experiments, cell studies and biomarker changes can justify further research, but a claim about wrinkles, mobility, disease or survival needs that outcome measured in people. Absolute differences, comparison groups, follow-up and withdrawals matter more than the novelty of the term.

The fourth is legal status in the market where the product is sold. A clinical paper does not authorize a product, and sale on a website does not prove authorization. APPI News could not verify the classification or authorization of exosome, NAD-related or stem-cell-labeled products in every country at the time of writing.

Evidence does not transfer to every group

Pregnancy and breastfeeding

Many dietary supplements have not been tested during pregnancy or breastfeeding, according to the US National Center for Complementary and Integrative Health. General adult studies cannot establish fetal, infant or maternal safety, so these groups need advice from a clinician familiar with the exact product.

Children

Children were not the population studied in the adult reviews cited here. Adult evidence and serving instructions cannot establish pediatric safety or benefit, and a clinician should assess any proposed use.

Chronic conditions and regular medicines

Supplements can interact with prescription or over-the-counter medicines and may pose different risks for people with medical conditions. A clinician or pharmacist needs the complete ingredient list, regular medicines and planned procedures to assess those risks.

Frequently asked questions

Does a real research term make an anti-aging claim credible?
No. The claim must match a defined product, route, population and human outcome. A laboratory mechanism or animal result can support further testing without establishing a consumer benefit.

Do NAD+ precursors reverse aging?
The 2026 review found consistent changes in NAD-related biomarkers but inconclusive effects on health and function. It did not establish longer life, disease prevention or reversal of biological aging.

Do exosome skin studies validate every exosome product?
No. The July 2026 review rated the facial-rejuvenation evidence as low or very low certainty and found substantial differences between studies. Its findings cannot be assigned to an untested capsule, cream, gel or injection.

Does “stem cell” on a label identify a stem-cell treatment?
No. A genuine cell-based intervention has a defined cell source, manufacturing process, route and regulatory pathway. A label that does not identify its material cannot borrow evidence from a different stem-cell treatment.

What makes a peptide claim testable?
The product must identify the peptide and formulation, then provide human evidence using the same route for the advertised outcome. Evidence about collagen, a blood marker or a laboratory mechanism does not establish every peptide claim.

WHO and UNICEF tie child development screening to tracked follow-up

APPI News Editorial — Wed, 12 Aug 2026 00:00:00 GMT

A 2025 systematic review found that all six included studies, covering 689 children aged six or younger with global or nonspecific developmental delay, reported improvement in at least one developmental domain. The review included no randomized controlled trials and rated the certainty of evidence low to very low. Those findings do not establish that any one program will produce the same result for an individual child.

A separate 2024 policy report shifts attention from detection to the handoffs that follow it. The joint report from the World Health Organization (WHO) and UNICEF distinguishes point-in-time screening from continuous developmental monitoring and defines comprehensive assessment as the step that can establish a diagnosis, describe functioning, identify family needs and connect families to services.

A screening result identifies risk, not a diagnosis

A standardized developmental screening questionnaire or checklist looks for skills below those expected at a given age across language, movement, cognition, behavior and emotion. It does not determine the cause, decide which services are needed or describe a child's full developmental profile.

A clinical report from the US-based American Academy of Pediatrics says concerns identified through surveillance or screening should lead to further developmental and medical evaluation, referral when indicated and earlier follow-up visits. The report treats surveillance, screening and diagnostic evaluation as separate parts of ongoing care.

WHO guidance published in 2024 places growth and developmental review within regular, scheduled well-care contacts for children and adolescents. National schedules and service entry points differ, so the screening timetable used in one country should not be presented as a global rule.

Loss of acquired skills calls for urgent assessment

Queensland Health guidance in Australia classifies acute deterioration in function, major loss of previously acquired skills, sudden weakness, slurred speech or seizures as emergency referrals. These changes call for urgent medical assessment through the local emergency route rather than waiting for the next screening or referral appointment.

An isolated concerning screen without an acute loss of function is a different situation. It still needs a documented next step, but whether that step is repeat screening, developmental assessment or specialty evaluation depends on the child's findings and the services available where the child lives.

Follow-up has more than one handoff

A workable pathway starts with developmental monitoring, uses validated screening when indicated and continues to assessment and individualized support. Each transition needs a named destination, a responsible service and a way to confirm that the referral was received.

The WHO-UNICEF report says a comprehensive assessment can include developmental history, caregiver concerns, structured tools, observation of family interaction, the home environment, social support and links to early-intervention services. Depending on the child's profile, the professionals involved may work in medicine, psychology, hearing, speech and language, motor development, education or social support.

Assessment and support can proceed in parallel where the local system allows. The report says suitable developmental support should begin once a need is established rather than waiting for every laboratory test, consultation or place in a formal program.

Regional data show where referrals can break

In the selected European and Central Asian systems covered by the report's survey, the usual wait for a comprehensive developmental assessment ranged from a few weeks to three months. That range describes the covered systems at the time of data collection, not a current global benchmark.

Situation analyses cited for Serbia and North Macedonia estimated that about 15 percent to 24 percent of children expected to receive a comprehensive assessment did not receive one. The regional report also described weak feedback between primary care and early-intervention services and problems tracking referral outcomes.

A referral therefore cannot be counted as completed care. Travel, cost, work and caregiving duties, language, accessibility and fragmented agency rules can affect whether a family reaches the next service, but the report does not provide one international rate for each barrier.

Six records make the next step traceable

The WHO-UNICEF and American Academy of Pediatrics process descriptions point to six pieces of information that can travel with a child across services. They record what happened and what comes next; they are not a home diagnostic tool.

Observed change: the specific skill or behavior, its setting and frequency, and whether a previously acquired skill was lost.
Screening record: the date, tool, age at screening and result, using a copy of the original report when available.
Clinical decision: whether the plan is monitoring, repeat screening, comprehensive assessment or another medical evaluation.
Referral record: the receiving service, referral date, contact details and expected response date.
Interim support: the support offered while assessment or formal services are pending and who will review progress.
Access barriers: transport, cost, scheduling, language, accessibility or caregiving constraints that the service needs to address.

Recording those fields can make a missed handoff visible, but it does not shift coordination entirely onto families. The WHO-UNICEF report calls for feedback from referral services, contact with families when appropriate and health-information systems that record referrals and their outcomes.

Early-intervention evidence remains uneven

The six programs in the 2025 systematic review ranged from multidisciplinary rehabilitation to parent-mediated and community-based services. The authors used a narrative synthesis because program design and outcome measures differed, and most included studies had a moderate or high risk of bias.

The study population also matters: the review covered children already described as having global or nonspecific developmental delay, not an unselected group with concerning screening results. Its findings cannot establish the benefit, content or preferred intensity of services for every child who has one concerning screen.

Early intervention should therefore not be described as guaranteeing that a child will reach the same developmental trajectory as peers. Comprehensive assessment is intended to identify the child's and family's needs, after which goals and locally available support can be matched to that profile.

Program performance starts after the screening count

The WHO-UNICEF framework calls for health-information systems to record children monitored, identified risks, delays or disabilities, referrals and referral outcomes. A raw count of completed screens cannot show whether families reached assessment or support.

Those fields would allow policymakers to examine time to assessment, the share of referrals completed, services begun, continued participation and reported access barriers. This is an inference from the report's monitoring framework; the report does not prescribe a single global scorecard.

Comparable national data remain limited. APPI News could not find a current international dataset showing how many children with a concerning developmental screen complete assessment and enter support across countries at the time of writing.

Known risks can justify a different route

The US-based American Academy of Pediatrics says children with known high-risk conditions may need closer developmental monitoring, intervention when indicated or direct referral rather than waiting for a routine screen. A clinical team may set an individualized pathway for a child born preterm or already followed for a genetic, neurological, hearing, vision or chronic health concern.

General screening schedules are designed for broad populations and should not delay a condition-specific follow-up plan. A normal screening result also does not override a clinician's concern when a child has lost skills or developed new neurological signs.

Doctor endorsements, ‘clinical proof’ and patents do not prove efficacy

APPI News Editorial — Tue, 11 Aug 2026 12:00:00 GMT

World Medical Association (WMA) guidance reaffirmed on October 19, 2024 tells physicians appearing in media to provide objective, evidence-based information and avoid recommending unproven products. It also tells physicians to describe material risks and avoid commercial promotion that could compromise professional integrity.

A medical title, the phrase “clinically proven” and a patent each refer to a different kind of record. None by itself establishes that the supplement on sale produces the advertised health outcome, and rules governing those claims differ by market.

When a supplement reaction needs urgent care

The United Kingdom National Health Service lists sudden swelling of the lips, mouth, throat or tongue, trouble breathing or swallowing, sudden confusion and fainting as signs of a serious allergic reaction. If these symptoms begin after taking a supplement, stop using the product and call the local emergency service immediately.

Children, people who are pregnant or breastfeeding, people with chronic conditions and anyone taking regular medicines need a separate safety assessment because evidence and interaction risks can differ. The US National Center for Complementary and Integrative Health says supplements may interact with medicines or pose risks with some medical conditions, many have not been tested in pregnancy, breastfeeding or children, and side effects warrant stopping the product and contacting a clinician.

A white coat does not transfer evidence to a product

The WMA guidance is an international professional standard rather than a global law. It does not make every physician appearance illegal, but it separates public education from named-product promotion and says medical information should remain objective and evidence-based.

US Federal Trade Commission guidance says an advertiser using an expert endorser should confirm relevant qualifications, ensure the expert made an assessment recognized as adequate in the field and disclose any material connection to the advertiser. The same guidance says an endorsement cannot convey a claim that would be deceptive or unsupported if the advertiser made it directly.

European Union law takes a different route for food claims. Regulation (EC) No 1924/2006 requires nutrition and health claims to rest on generally accepted scientific data and prohibits food health claims that refer to recommendations by individual doctors or health professionals.

A useful credential check identifies the speaker's full name, profession, licensing country, relevant field and financial relationship with the seller. A valid medical credential establishes identity and training; it does not convert an advertising statement into evidence for the product.

“Clinically proven” is a claim about evidence, not a certificate

The US Federal Trade Commission generally regards randomized controlled human trials as the most reliable support for health-benefit claims and says independently conducted replication adds weight to the evidence. Its guidance also says research quality matters more than the number of weak studies.

The study must match the claim. The relevant record identifies the tested formulation, study population, comparison group, duration, prespecified outcomes, adverse events and full results; a paper about one isolated ingredient does not automatically support a different mixture sold under the same marketing term.

The World Health Organization says a clinical trial should be registered before the first participant is recruited and defines registration as publication of agreed information about the trial's design, conduct and administration. A registry entry makes the planned methods visible, but it does not show that a trial was completed or that its results favored the product.

Company funding does not by itself invalidate a study. It makes prospective registration, complete outcome reporting, disclosed conflicts, methodological quality and independent replication relevant when the evidence is weighed as a whole.

A patent protects an invention, not a health outcome

The World Intellectual Property Organization (WIPO) defines a patent as an exclusive right granted for an invention and lists novelty, an inventive step, industrial applicability and adequate technical disclosure among key patentability conditions. Those conditions assess an invention, not whether a finished supplement improves a clinical outcome.

WIPO says patents are territorial rights and that there is no universal international patent. A usable patent claim therefore needs a publication or grant number, the issuing office, the owner, its current status and the specific claims that define what is protected.

A patent can cover a compound, composition, manufacturing process or other technical feature without covering the finished product's advertised effect. A separate record from the responsible regulator is needed to establish whether a named product or health claim is authorized in a named market, and availability and regulatory status vary by country.

Three checks keep the claims separate

Endorser: The verifiable records are the person's identity, relevant qualification, licensing jurisdiction, role in assessing the exact product and financial connection to the seller. None of these details can replace product-specific clinical evidence.

Clinical evidence: A full citation or trial registration number should lead to the methods and results for the tested formulation. The comparison group, participant count, duration, outcome definitions, adverse events, funding and surrounding evidence show how far the conclusion can travel.

Patent: The patent number should lead to an official office record showing whether the item is an application or grant, where it applies, who owns it and what the claims cover. That record can establish an intellectual-property position, not a health benefit.

The applicable advertising and product rules come from the jurisdiction where the supplement is marketed. APPI News could not find a published global dataset measuring how often supplement ads use doctor, clinical or patent claims at the time of writing.

Frequently asked questions

Does a doctor endorsement prove that a supplement works?
No. Credentials can establish the endorser's training, while disclosed ties show possible commercial interests; the claimed effect still requires evidence for the product.

Does “clinically proven” mean that several strong trials exist?
No. The phrase alone does not identify a study, and the evidence cannot be assessed until the formulation, methods, results and wider body of research are available.

Does a patent establish safety or effectiveness?
No. A patent defines rights over an invention in a jurisdiction; it is separate from clinical evidence and market authorization.

Are all three labels meaningless?
No. Each can point to a record that is worth checking, but the record must match the advertised product and claim.

WHO diet guidance overlaps for blood pressure, glucose and lipids

APPI News Editorial — Mon, 10 Aug 2026 17:05:40 GMT

The World Health Organization (WHO) updated its healthy-diet guidance on January 26, 2026, giving adults managing blood pressure, glucose or cholesterol a shared set of priorities. The guidance favors whole grains, pulses, fruit and vegetables while limiting sodium, free sugars, saturated fat and trans fat, but it does not turn three different clinical findings into one universal meal plan.

A flagged screening result should be reviewed with a clinician who can confirm what was measured, whether repeat testing is needed and which treatment target applies. Diet can support treatment, but it does not establish a diagnosis or replace prescribed medicine.

When symptoms require urgent care

WHO says blood pressure of about 180/120 mmHg or higher accompanied by chest pain, difficulty breathing, severe headache, confusion, vomiting or vision changes requires immediate care. A meal change should not delay the local emergency service when these symptoms occur.

The United Kingdom's National Health Service lists seizure and unconsciousness as signs of severe hypoglycemia. A person with either sign, or one who is not responding normally, needs help through the local emergency service.

The shared baseline has measurable limits

WHO's May 2026 sodium fact sheet recommends less than 2,000 milligrams of sodium a day for adults, equivalent to less than five grams of salt. The total includes sodium already present in bread, processed meat, snack foods, sauces, dressings and instant products, not only salt added at the table.

WHO advises people older than 10 to aim for at least 400 grams of fruit and vegetables and 25 grams of naturally occurring dietary fiber a day, while keeping free sugars below 10 percent of energy. Whole grains, vegetables, whole fruit and pulses are the preferred carbohydrate sources; fruit juice still contributes free sugars and should be limited.

WHO's updated fat guidance recommends no more than 10 percent of energy from saturated fat and no more than 1 percent from trans fat. It favors replacing those fats with polyunsaturated or plant-derived monounsaturated fats, or with carbohydrate from foods that contain naturally occurring fiber.

Build meals from components rather than a forbidden list

A practical meal can combine vegetables or pulses, a whole grain or another minimally processed starchy food, and a protein source such as beans, lentils, tofu, fish, eggs or lean meat. Nuts, seeds, avocado and plant oils can supply unsaturated fat, while portions still need to fit the person's energy needs and treatment plan.

Fresh produce is not the only workable option. WHO says frozen and canned fruit and vegetables can fit a healthy diet when they do not contain added sugars or excess sodium, making plain frozen vegetables, no-added-sugar fruit and lower-sodium canned pulses useful time-saving choices.

Breakfast could pair unsweetened oats with whole fruit and plain yogurt, or whole-grain bread with an egg and vegetables. For another meal, a whole grain, frozen vegetables and beans or fish can be assembled without relying on a heavily salted sauce.

These examples are meal structures, not fixed prescriptions. A person tracking carbohydrate for diabetes, restricting potassium for a clinical reason or trying to prevent unintended weight loss may need different ingredients and portions.

Use the label to compare ready-made meals

Start with the declared serving size and the amount actually eaten. Compare sodium, saturated fat and the available sugar measure across products using the same quantity, because a small stated serving can make a package look lower in those nutrients than the full meal.

Labels do not use one worldwide format, so the relevant comparison may be per serving, per 100 grams or both. “Free sugars” is WHO's public-health category, while a national label may instead disclose total sugars, added sugars or another required measure; use the category printed rather than treating different measures as interchangeable.

For a packaged meal, look for vegetables or pulses, a minimally processed carbohydrate and a protein source before adding extras. Sauces, dressings, soup bases and processed meats can raise sodium quickly, so compare them separately and use less when the meal already contains a substantial amount.

Water and unsweetened drinks avoid adding free sugars to the meal. WHO treats whole fruit as a preferred carbohydrate source and advises limiting fruit juice, but the amount and timing may still matter when a diabetes plan links carbohydrate intake with medication.

Restaurant choices follow the same checks

Steamed, boiled, baked or grilled dishes generally make added frying fat easier to avoid than deep-fried food, although sauces and marinades can still add sodium or sugar. A vegetable or pulse side and a whole-grain option, where available, can improve the balance without requiring a special “diet” menu.

Ask for sauces or dressings separately when the restaurant can accommodate the request, then use only what is needed. Soup, gravy, cured meat and salty condiments can be major sodium sources even when the main ingredient is lean.

Restaurant recipes and portions often cannot be verified from appearance. One meal also cannot show whether the weekly pattern meets a nutrient target, so uncertainty should be recorded rather than converted into a precise estimate.

Each condition changes a different part of the plan

High blood pressure: Total sodium is the first shared number to check, but a clinician may set a different blood-pressure or sodium target when kidney disease, heart failure or medication is involved. WHO also advises people with hypertension to take medicines as prescribed, so lower-sodium meals should not be used as a reason to stop treatment.

Diabetes or high glucose: WHO says diabetes care can combine diet, physical activity, medication and screening, and that some people with type 2 diabetes need medicine to manage blood glucose. People using insulin or another medicine that can cause hypoglycemia should agree on major carbohydrate reductions, fasting or skipped meals with their diabetes team.

Abnormal blood lipids: Replacing saturated and trans fats matters more than trying to remove all fat from meals. Diet is one part of cardiovascular-risk management, while the need for lipid-lowering medicine depends on the lipid result, medical history and the clinical guideline used in the reader's country.

Kidney disease and life stage require separate advice

Chronic kidney disease: Kidney Disease: Improving Global Outcomes advises an individualized approach to potassium for people with stage G3 to G5 chronic kidney disease who have hyperkalemia, with assessment by a renal dietitian or another accredited nutrition professional. Potassium-based lower-sodium salt substitutes and generic advice to increase high-potassium foods are therefore not suitable for everyone.

Children and pregnancy: Adult sodium, energy and portion guidance should not be copied directly for children, whose needs change with growth. Pregnant or breastfeeding people need enough energy and nutrients for their life stage, and those with diabetes, hypertension or kidney disease should use a plan developed with their maternity and clinical teams.

Older adults and people taking medicine: WHO's Integrated Care for Older People approach identifies malnutrition as a decline that health services should assess and calls for person-centered care plans. Poor appetite, difficulty chewing, unintended weight loss or a food change that affects medicine timing warrants review by a clinician or dietitian.

Meal preparation can reduce daily decisions

Choose a small group of repeatable components: plain frozen vegetables, cooked whole grains or pulses, and unsalted or lightly seasoned protein foods. Preparing several portions at once can make the intended combination available on busy days without assigning the same portion to every household member.

Keep sauces and salty condiments separate from the base meal, then measure what is added. For packaged components, record the serving actually used so sodium, saturated fat and sugars are not counted from an unrealistically small label portion.

A short food record can show recurring sources of sodium, sugary drinks or saturated fat more clearly than judging one lunch. Review that pattern alongside follow-up blood pressure, glucose and lipid results with the treating team rather than expecting a single food swap to prove a clinical effect.

Frequently asked questions

Do high blood pressure, high glucose and abnormal cholesterol require the same diet?
They share a baseline of minimally processed foods, more fiber and limits on sodium, free sugars, saturated fat and trans fat. Their treatment targets still differ, and diabetes medication, kidney function and cardiovascular risk can change the plan.

Does fruit need to be removed when glucose is high?
WHO includes whole fruit among preferred carbohydrate sources and distinguishes it from juice, which contributes free sugars. Portion and timing should be matched to the person's diabetes plan rather than applying a blanket ban.

Is a lower-sodium salt substitute always a better choice?
No, because many substitutes replace some sodium with potassium. People with kidney disease, a history of high blood potassium or medicines that affect potassium should ask their clinical team before using one.

Can packaged or restaurant food fit the plan?
It can fit when the full portion and the wider eating pattern are considered. Compare labels on the same basis, account for sauces and drinks, and avoid claiming an exact nutrient total when a restaurant does not publish one.

Influencer supplement claims need disclosure and matching evidence

APPI News Editorial — Mon, 10 Aug 2026 12:00:00 GMT

The European Union's 2024 annual report says a screening found that 97 percent of the influencers checked posted commercial content, but only one in five consistently identified it as advertising. The screening examined influencer marketing generally, so the figures do not estimate disclosure rates for supplement posts alone.

A supplement recommendation presents three separate questions: whether the post is advertising, what health outcome it promises and whether evidence supports that exact promise. A visible sponsorship label answers only the first question.

Urgent reactions take priority over an advertisement check

The United Kingdom National Health Service lists sudden swelling of the lips, mouth, throat or tongue, difficulty breathing or swallowing, sudden confusion and fainting as signs that can require immediate hospital treatment. If these symptoms begin after consuming a supplement, call the local emergency service immediately rather than continuing to investigate the post.

Pregnancy and breastfeeding

The US National Center for Complementary and Integrative Health says many supplements have not been tested in people who are pregnant or breastfeeding. A clinician or pharmacist should assess the exact ingredients before use in either group.

Children

The same US source says many supplements have not been tested in children. Evidence from adults cannot establish pediatric safety for an untested product, so a clinician or pharmacist should assess the exact supplement before a child uses it.

Chronic conditions, surgery and regular medicines

The US center says supplements may interact with medicines, pose risks with some medical conditions or affect surgery. People in these groups should give a clinician or pharmacist the full ingredient label and a list of regular medicines before use.

Check one: identify the commercial relationship

The US Federal Trade Commission says a material connection can include payment, employment, a personal or family relationship, and free or discounted products or services. Its guidance says the disclosure should accompany the endorsement, use clear language and be hard to miss.

The US guidance also says a live stream should repeat the disclosure periodically because viewers may join after it begins. These instructions apply when US law governs the post; they do not establish the required wording in every country.

United Kingdom Competition and Markets Authority guidance updated on September 3, 2025 covers direct payment, commission, free products and discounts, regardless of an influencer's follower count. That guidance applies to content governed by United Kingdom consumer law, including posts about an influencer's own products.

A disclosed commercial connection does not make a recommendation true or false. It gives readers information needed to weigh the endorser's financial interest separately from the product claim.

Check two: capture the complete health claim

Save the product name, exact words, images, spoken statements, sales link, country of sale and date viewed. US Federal Trade Commission guidance says an advertisement's overall impression includes express and implied claims conveyed by its text, product name, charts, graphs and other images.

Product names, demonstrations and visuals can therefore communicate a health promise that does not appear word for word in the caption. The evidence check needs to address that complete promise, not a narrower phrase selected by the seller.

For foods marketed in the European Union, the European Commission provides a public register of permitted nutrition claims and authorized and non-authorized health claims. The register answers an EU claim-status question; it does not determine how another jurisdiction classifies the same product or wording.

For any other market, identify the authority responsible for the product category in the country of sale before searching for the product or claim. An influencer's unqualified statement that a supplement is “approved” does not provide a verifiable status without a country and agency. If no matching official record can be found, record the status as unverified rather than assuming approval or illegality.

Check three: test the evidence, not the testimonial

The US Federal Trade Commission's 2022 guidance says individual consumer experiences cannot substantiate a health-product effect, generally treats randomized controlled human trials as the most reliable support for health-benefit claims and gives added weight to independent replication. A sincere account of feeling better after taking a supplement remains an anecdote because other changes or expectations may explain the timing.

The cited research must match the finished product, ingredients, route, population, comparison, duration and outcome in the post. The same US guidance says animal and laboratory studies can supply background information but cannot establish a claimed benefit in people without confirmation from human trials. A paper on one ingredient does not automatically support a mixture sold under a different formulation.

Cochrane says systematic reviews examine the research that meets predefined criteria for a question and are more reliable than individual studies. A review still has to cover the product, population and outcome claimed in the advertisement.

A 2017 joint statement hosted by the World Health Organization says prospective trial registration and timely public disclosure of results reduce reporting bias. Compare a registry entry with the paper's participant count, planned outcomes and completion status, but do not treat registration itself as a favorable result.

Read the full paper rather than a sales-page summary, note who funded it and check whether independent researchers reproduced the finding. Search for later trials, systematic reviews, corrections and results that did not favor the product before judging the evidence as a whole.

A three-question screen for the next supplement post

First: Is the commercial relationship visible? Look for a clear disclosure where the recommendation appears, including in the video or livestream rather than only on a profile page. Treat gifts, discounts, commissions and ownership ties as relationships that may require disclosure under the applicable law.

Second: What exact outcome does the post promise? Record the words and visuals, then identify the country of sale and the authority responsible for that product category. A sponsorship label does not make a disease, prevention or body-function claim lawful in that market.

Third: Does the evidence match the product? Open the full source and compare the formulation, human population, comparison group, duration and measured outcome with the advertisement. A personal story, animal experiment or isolated ingredient paper cannot by itself establish the claimed result for the finished supplement.

A failed disclosure check identifies missing information about a commercial relationship; it does not prove that the product claim is false. A failed evidence check means the claimed effect was not verified, not that research has established the effect is impossible.

APPI News could not verify disclosure rules, product registers and reporting channels in every market at the time of writing. Readers need the regulator and advertising rules for the country where the supplement is offered because classification, permitted claims and enforcement vary by jurisdiction.

Frequently asked questions

Does an “ad” or “sponsored” label prove that a supplement works?
No. The label discloses a commercial relationship, while the health claim still needs market-specific regulatory checks and evidence that matches the finished product.

Does a free product count as sponsorship?
US Federal Trade Commission and United Kingdom Competition and Markets Authority guidance both treat free or discounted products as relationships that can require disclosure. Other jurisdictions may define and enforce the obligation differently.

Is one human trial enough?
Not automatically. Its design, size, population, formulation, outcomes, funding and consistency with the wider body of evidence determine how much it supports the advertised claim.

Where can a suspected hidden advertisement be reported?
Reporting routes depend on the platform and country whose consumer or advertising law applies. Use the named national authority's official site rather than assuming that a regulator in another country can handle the post.

Heat alerts call for earlier action for children and older adults

APPI News Editorial — Mon, 10 Aug 2026 00:00:00 GMT

The World Health Organization (WHO) updated its global heat fact sheet on July 31, 2026, saying deaths and hospitalizations linked to extreme heat can occur on the day of an event and in the days immediately after it. The short interval makes official warnings a prompt for action before symptoms appear.

A household plan should connect each local warning to a decision: move an activity, shorten time outdoors, identify a cool place or check on someone who may need help. Emergency symptoms require a separate response and should not wait for an alert level to rise.

Confusion, seizures or collapse require emergency help

The US National Institute for Occupational Safety and Health (NIOSH) lists confusion, altered mental status, slurred speech, seizures and loss of consciousness as signs of heatstroke, which can be fatal if treatment is delayed. Hot, dry skin is one possible sign, but profuse sweating can also occur, so continued sweating does not rule out heatstroke.

Call the local emergency medical service, move the person to shade or a cool indoor place, remove outer clothing and begin cooling while help is on the way. NIOSH advises wetting the skin or clothing, applying cold wet cloths and moving air around the person while someone stays with them until emergency responders arrive.

Headache, nausea, dizziness, weakness, intense thirst and heavy sweating may accompany heat exhaustion. WHO advises moving to a cool place and drinking water when the person is alert, while persistent unusual symptoms or heat cramps lasting more than one hour need medical attention.

Use the local warning rather than a universal cutoff

WHO defines a heatwave through excess heat under local conditions and advises the public to stay informed about official heat warnings. A color category or temperature threshold from one country should not be substituted for the alert issued by the national or local authority where the activity will occur.

Check the forecast for the place and time of the planned activity, including the overnight period if the home stays hot. A lower alert category is not a guarantee of safety because risk also depends on exposure, physical effort, clothing, health, age and access to cooling.

Assign one person to check the warning before departure and another to confirm that water, shade and a cool retreat are available. The plan should also state which alert or condition will shorten, move or cancel an activity, using local health and weather advice.

Cooling, water and rest work as a package

WHO advises staying out of the heat during the hottest time of day, using shade, moving to the coolest room, taking cool showers or baths, wetting the skin and drinking water regularly. Cooling reduces heat gain, rest reduces heat produced by activity and water replaces part of what is lost through sweating.

This report does not set one daily fluid volume for every person. People whose clinician has limited their fluids, or who have heart or kidney conditions, need a plan matched to their condition rather than a generic cup count.

Ventilation also depends on the temperature difference between indoors and outdoors. WHO advises opening windows after dark only when outdoor air is cooler, blocking direct sunlight when it is hotter outside and using electric fans only below 40 degrees Celsius because hotter air can heat the body.

Children and older adults need earlier planning

Infants and children

Children depend on adults to change the route, activity and cooling arrangements before heat becomes a problem. WHO says children should never be left in a parked vehicle for any amount of time and should avoid direct sun during peak hours.

A caregiver should know where the child can cool down and should watch for unusual behavior, weakness or reduced responsiveness. Confusion, a seizure, collapse or loss of consciousness requires the emergency response described above.

Older adults

The US Centers for Disease Control and Prevention (CDC) says adults aged 65 and older may adjust less well to sudden temperature changes and are more likely to have chronic conditions or take medicines that affect temperature control or sweating. The agency advises staying cool and hydrated and arranging check-ins rather than assuming the person will ask for help.

The check-in plan should confirm access to a cool place, fluids and a working way to call for assistance. People with clinician-set fluid limits should ask how those limits apply during hot weather instead of increasing intake on their own.

Pregnancy

WHO's European office says the effects of heat in pregnancy depend on the frequency, intensity and duration of exposure and advises moving activity or travel to cooler conditions where possible. It also says reduced fetal movement is a reason to contact a midwife or pregnancy care provider, during a heatwave or at any other time.

Chronic conditions and medicines change the plan

WHO says heat places extra strain on the heart and kidneys and can worsen risks linked to cardiovascular, respiratory, mental health and diabetes-related conditions. The relevant trigger is therefore the person's condition and exposure alongside the official warning, not the air temperature alone.

US CDC clinician guidance says its recommendations reflect expert opinion, lists diuretics, anticholinergic drugs and some psychiatric medicines as potential heat-risk factors, and calls for individualized review before changing a dose, schedule or fluid restriction. Regular medicine should not be stopped or changed solely because a hot day is forecast.

A heat plan for someone with chronic illness can cover access to cooling, the permitted fluid range, medicine storage and whom to contact if symptoms develop. That plan is best settled with the treating clinician before a heat alert rather than improvised during one.

Work and sport need controlled exposure

US NIOSH workplace guidance calls for limiting time in heat, increasing recovery time in a cool area, providing drinking water, using a buddy system and activating a heat-alert program when the weather service forecasts a heatwave. Employers remain responsible for the rules and emergency procedures that apply in the country and workplace concerned.

NIOSH says new and returning workers should build exposure to hot conditions gradually over seven to 14 days. Its schedule for new workers starts at no more than 20 percent of usual heat exposure on day one and adds no more than 20 percent on each later day.

A 2023 International Olympic Committee consensus says sports organizers should monitor conditions before and during an event, provide shade, cooling and hydration, and develop a clear heat policy with the relevant sports federation. It also places responsibility on athletes, organizers, medical teams and federations rather than treating heat safety as an individual's test of endurance.

Workplace schedules and sports rules are not interchangeable. Each setting needs its own authority, exposure assessment, rest arrangements and practiced emergency response.

A five-point plan turns advice into triggers

The plan can fit on one page, but it needs named responsibilities and decisions. Review it when an official warning changes or when a participant's health, medicine or activity level changes.

Check the official local heat warning and forecast for the place and time of the activity.
Identify children, older adults, pregnant people and people with chronic conditions or daily medicines who may need earlier action.
Confirm shade, water, rest periods, a cool retreat and a way to contact local emergency services.
Use the applicable employer or sports policy to shorten, move or cancel strenuous activity and to phase in heat exposure.
After exposure, check for headache, nausea, dizziness or weakness and treat confusion, seizures, collapse or loss of consciousness as an emergency.

The person responsible for the plan should check conditions before departure and check everyone again after exposure. Any emergency sign should trigger immediate help and cooling, regardless of the forecast category.

AST-to-ALT ratios offer clues but cannot diagnose liver disease

APPI News Editorial — Mon, 10 Aug 2026 00:00:00 GMT

A 2024 guideline from the US-based American College of Gastroenterology (ACG) uses the ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) only as one part of an alcohol-associated hepatitis assessment. Raw enzyme values, symptoms, exposure history and other tests determine what follow-up is needed.

Jaundice or gastrointestinal bleeding needs prompt care

The United Kingdom's National Health Service says yellowing of the skin or whites of the eyes warrants urgent medical help and may occur with darker urine and paler stool. An AST-to-ALT ratio cannot identify the cause or make it safe to wait.

The same health service directs people who vomit blood and also have black stool, confusion, faintness, rapid or shallow breathing, cold, clammy and pale skin, or abdominal pain to emergency care. Its emergency number is specific to the United Kingdom; readers elsewhere need their local emergency service rather than another liver test.

Check raw values before calculating the ratio

The formula is AST divided by ALT. An AST of 40 U/L and ALT of 20 U/L give a ratio of 2.0, while an AST of 400 U/L and ALT of 200 U/L produce the same ratio. The calculation discards the tenfold difference between the two sets of raw values.

ACG's 2017 guideline says the degree of AST or ALT elevation helps direct the evaluation and recommends confirming an abnormal panel with repeat or clarifying tests. A clinician decides what needs confirmation from the complete report, symptoms and history rather than the ratio alone.

British Society of Gastroenterology guidance says abnormal liver blood tests should be interpreted with earlier results, medical history and the current clinical condition, and that the size of an abnormality does not necessarily show its clinical importance. The units and upper reference limits printed by the laboratory should stay with each result when values from different dates are compared.

Common patterns narrow questions but do not name a disease

ALT higher than AST

ACG lists viral hepatitis, fatty liver disease, alcohol-associated disease, autoimmune and inherited conditions, and medicine exposure among causes considered when AST or ALT is elevated. An ALT-predominant pattern does not by itself diagnose fatty liver disease or any other condition.

AST higher than ALT

The British guideline notes that AST is abundant in skeletal, cardiac and smooth muscle and asks clinicians to include muscle injury in the history. A higher AST can therefore reflect liver or non-liver tissue, and the alcohol and muscle history both matter.

ACG's 2024 guideline uses an AST-to-ALT ratio above 1.5 only among several criteria for probable alcohol-associated hepatitis, alongside recent jaundice, sustained heavy alcohol use, a defined AST and bilirubin pattern, and exclusion of other causes. A screening ratio of 2.0 does not supply those clinical conditions and cannot establish the diagnosis.

Both values inside the laboratory range

The British guideline says liver blood tests used in isolation are neither specific diagnostic tools nor specific exclusion tools. A ratio calculated from two in-range results does not override an existing follow-up plan based on chronic hepatitis, cirrhosis or another established risk.

Bring trends and exposure history to follow-up

The most useful record combines the full laboratory report with timing and exposure history. It lets a clinician compare the pattern across dates without losing the laboratory's reference limits or the circumstances around each blood draw.

The current report and available earlier reports show the exact AST and ALT values, units, dates and upper reference limits.
Other available results include bilirubin, albumin, alkaline phosphatase, GGT, the full blood count and any clotting tests already performed.
Earlier ultrasound reports and hepatitis B or C test results show what has already been assessed.
A complete exposure list covers alcohol, prescription and nonprescription medicines, herbal products and dietary supplements.
Notes on recent infection, muscle injury or strenuous activity place each blood draw in context.

The British guideline specifically calls for a history covering symptoms, other illnesses, prescribed and nonprescription products, alcohol, metabolic risks and muscle injury. Matching one ratio to an online label cannot replace that cause-based review.

Children and pregnancy require separate interpretation

A North American pediatric guideline uses child-specific ALT limits and says AST has not been independently validated as a screening test for pediatric fatty liver disease. A child's results need pediatric assessment rather than adult ratio rules.

The International Federation of Gynecology and Obstetrics (FIGO) provides pregnancy-specific laboratory ranges and recommends multidisciplinary care for new or pre-existing liver disease during pregnancy. Pregnant people with symptoms or an abnormal panel need obstetric assessment rather than self-interpretation against adult screening patterns.

People with chronic hepatitis, cirrhosis, metabolic disease or medicines that require monitoring also need an individualized plan. They should discuss changes in results, treatment or supplements with the clinician managing that condition.

Frequently asked questions

Does an AST-to-ALT ratio above 2 mean alcohol-associated liver disease?
No. ACG uses a lower threshold only inside a multi-part profile for probable alcohol-associated hepatitis, and the ratio alone cannot establish alcohol exposure, exclude other causes or diagnose disease.

Does ALT above AST mean fatty liver disease?
No. Viral, autoimmune, inherited and medicine-related causes can also raise aminotransferases, so the history and other tests determine the evaluation.

Can muscle injury change the ratio?
Yes. AST is abundant in muscle, so a recent muscle injury can raise it without identifying the liver as the source.

Do in-range AST and ALT values end follow-up?
Not automatically. Existing diagnoses, symptoms, prior results and risk-based monitoring remain relevant even when one panel falls inside the laboratory range.

Older adults need checks now and for weeks after a head injury

APPI News Editorial — Mon, 10 Aug 2026 00:00:00 GMT

The US Centers for Disease Control and Prevention (CDC) says symptoms of a mild traumatic brain injury may appear immediately or hours to days after the injury. Older adults can also develop a chronic subdural hematoma after a minor blow, so an initially normal appearance does not set an endpoint for observation.

Emergency signs come before home observation

Call the local emergency service if the person remains unconscious, cannot be woken, has a seizure, develops new weakness or numbness, or has trouble speaking or coordinating movement. The US CDC also lists a worsening headache that does not go away, repeated vomiting, one pupil larger than the other, increasing confusion, restlessness and unusual behavior as danger signs requiring immediate emergency care.

England's National Health Service (NHS) says urgent medical advice is needed after a head injury when the person vomits, feels dizzy, has a condition that affects clotting or takes medicine that reduces clotting. It calls for emergency help when someone cannot wake or stay awake, has a seizure, develops new weakness or problems with walking or speech, or sustained a high-speed or penetrating injury.

Do not delay emergency care to finish a checklist. Give responders the information already available, then bring a written medication list, medicine containers or photographs of their labels if this can be done without slowing transport.

Record six facts about the injury

A short factual record helps a clinician reconstruct what happened and compare the person's current condition with the pre-injury baseline. Record uncertainty instead of filling gaps from memory.

Time: Write the date and best estimate of the exact time of the fall or blow.
Mechanism: Note what caused the injury, the approximate fall height or speed, and whether another body part was injured.
Impact: Record where the head struck, any visible wound, and any new neck pain.
Immediate response: Note any loss of consciousness, memory gap, vomiting, seizure or unusual behavior.
Baseline: Describe the person's usual speech, alertness, memory, walking and use of both arms and legs.
Medicines: List every prescribed and nonprescription medicine, especially anticoagulants and antiplatelet medicines, with the last known dose time.

A familiar adult should cover the first 24 hours

Home observation is appropriate only after a clinician or local urgent-care service has decided the person does not need hospital care, or after hospital discharge with written instructions. The caregiver should keep those instructions available and use their return thresholds rather than a generic schedule.

The caregiver should know the person's usual behavior and check for changes in conversation, alertness, speech, balance, limb use, headache, nausea and vomiting. Write the time beside each observation and follow any intervals or return instructions supplied by the treating service; this guide does not set an hourly waking schedule.

England's National Health Service says a person sent home after a minor head injury does not need to stay awake when tired, but an adult should remain with them for at least 24 hours. Abnormal difficulty waking is an emergency sign, and sleeping pills should not be added during recovery unless a clinician advises them.

Medication and dementia change the assessment

The US CDC says traumatic brain injuries may be missed or misdiagnosed in older adults because symptoms overlap with conditions such as dementia, and that anticoagulant and antiplatelet medicines may increase the risk of bleeding in the brain after an injury. A caregiver should report the person's usual cognition and independence, every regular medicine and the last known dose time.

The UK Medicines and Healthcare products Regulatory Agency says people taking an oral anticoagulant should not suddenly stop treatment or change the dose unless their healthcare team directs them. A caregiver should not decide to skip an anticoagulant after the injury; an urgent-care clinician must balance bleeding and clotting risks.

A known bleeding or clotting disorder also requires prompt clinical advice after a head injury. When the person has dementia or another pre-injury cognitive impairment, the caregiver should state the usual level of memory, speech and independence because new confusion or slowing may otherwise be mistaken for the baseline.

New changes can appear over the following weeks

The US National Library of Medicine says chronic subdural hematoma is more common in older adults because age-related brain shrinkage stretches the veins between the brain and its outer covering, leaving them more likely to tear after even a minor head injury. Blood can collect slowly, and symptoms may appear weeks or months after the original event.

Seek prompt medical assessment for a new or worsening headache, increasing sleepiness, confusion, memory or personality change, slurred speech, trouble swallowing, new unsteadiness or repeated falls, or weakness or numbness in the face, arm or leg. A seizure, loss of consciousness or inability to wake still requires emergency help even when it occurs long after the injury.

Record the first time each change appeared and whether it is constant, intermittent or worsening. Tell the clinician about the earlier head injury even if the blow seemed minor or the person was not assessed at the time.

Keep a timeline that clinicians can scan

A usable log separates baseline function from changes after the injury. It should remain short enough to read during triage.

Event line: Date, time, place, cause and point of impact.
Baseline line: Usual alertness, memory, speech, walking, vision, hearing and daily assistance needs.
Symptom lines: Time-stamped headache, vomiting, drowsiness, confusion, behavior, speech, balance and limb changes.
Medication line: Medicine names, purpose if known, last dose time and any anticoagulant alert card.
Care line: Health service contacted, examination time, scan result if one was performed, and written return or follow-up instructions.
Observer line: Name of the person making each entry and a contact number for follow-up questions.

APPI News could not find a published, validated home checklist that allows a caregiver to rule out delayed intracranial bleeding. The record supports communication with clinicians; it does not diagnose concussion, exclude a hematoma or decide whether CT imaging is needed.

Frequently asked questions

Does the absence of a lump rule out bleeding?
No. A visible scalp lump describes the surface injury and cannot exclude bleeding around or within the brain; symptoms, medicines, the injury mechanism and a clinical examination guide the next step.

Can an older adult sleep after a head injury?
Sleep is allowed after a health service has said home care is appropriate, unless the discharge instructions say otherwise. A responsible adult should stay for the first 24 hours and seek emergency help if the person becomes abnormally difficult to wake.

Is observation finished after 24 hours?
No. The first 24 hours are a focused supervision period after home discharge, while some concussion symptoms can appear over days and chronic subdural hematoma symptoms can emerge weeks or months later.

Should an anticoagulant be stopped after the injury?
Not on a caregiver's decision. The medicine name and last dose time should be reported immediately, and a clinician should decide whether treatment continues, pauses or changes.

Natural and additive-free food labels need a closer reading

APPI News Editorial — Sun, 09 Aug 2026 12:00:00 GMT

Codex Alimentarius guidance treats “natural” and absence claims as conditional marketing claims, not proof that a packaged food is safer or more nutritious. The ingredient list provides more specific evidence, but national rules determine how each claim and additive must be declared.

The wording on the front of a package still matters. It identifies the exact promise a manufacturer has chosen to make, such as “no added sugar,” “no preservatives” or “zero calories.” The next step is to test that narrow promise against the qualifier, ingredient list, nutrition panel and storage instructions instead of extending it into a broader health claim.

“Natural” follows national practice, not one global definition

The Codex Alimentarius Commission's guidance says food claims should not be false, misleading or deceptive and that the marketer should be able to justify them. Codex is the food-standard body established by the Food and Agriculture Organization of the United Nations and the World Health Organization (WHO). Its texts provide an international reference, while governments decide how to adopt and enforce them.

The same guidance places “natural,” “pure,” “fresh,” “home made” and organic-production terms under the practices of the country where the food is sold. “Natural” is therefore not a single international certification. A shopper needs the rule for the market of sale before assuming the term excludes a particular process or ingredient.

An absence claim is narrower than the package impression

Codex guidance allows a claim highlighting the absence or non-addition of a substance only under stated conditions. The substance should be one consumers would normally expect in that food, and the claim must not mislead. If another substance supplies an equivalent characteristic, the substitution should be disclosed with equal prominence.

That distinction matters for claims such as “no added sucrose” or “no preservatives.” The first does not, by itself, say that a product contains no other sugars. The second does not describe calories, sodium, allergens, processing, shelf life or the complete formulation.

“Zero” also needs its noun and its legal context. A zero claim may refer to sugar, calories, alcohol, trans fat or another component, and jurisdictions can set different definitions or thresholds. The front-panel word alone cannot establish what was measured or which rule applies.

The ingredient list answers a different set of questions

The Codex labeling standard says ingredients in most multi-ingredient packaged foods should appear in descending order of their weight when the food was manufactured. That order can show whether a highlighted ingredient is a major part of the formulation. It does not show which ingredient is more nutritious, and the order of ingredients present in similar amounts may reveal little about their exact proportions.

The standard also says additive functional classes, such as preservative, sweetener or emulsifier, should appear with the specific name or a recognized number as required by national legislation. This lets the label describe both what an additive does and which additive was used. Processing aids and additives carried over at levels too low to perform a technological function can qualify for exemptions, so an ingredient list is not always a record of every substance used anywhere in production.

A practical reading starts with the claim's exact scope. Compare it with the product name and ingredient list, then check the nutrition panel, allergen declaration, date mark and storage directions. For supplements, confirm whether the product is regulated as a food, supplement or medicine in the market where it is sold, because the label category and permitted claims can differ by country.

Additive-free does not establish that a food is safer

WHO says the Joint FAO/WHO Expert Committee on Food Additives evaluates additives used in internationally traded food, while national authorities authorize specific uses and levels. The assessment applies to additives from natural sources and to synthetic additives. Safety depends on the substance, exposure, food category and permitted conditions of use rather than the origin implied by a marketing word.

WHO also says preservatives can slow decomposition caused by mold, air, bacteria or yeast and can help control contamination that causes foodborne illness. Removing a preservative does not automatically make a product unsafe, because manufacturers can use refrigeration, heat treatment, acidity, drying or packaging controls. It does mean that “preservative-free” alone cannot establish safety; the product's process, storage conditions and use-by instructions still matter.

A five-point check for front-of-pack claims

First, read the complete phrase rather than the largest word. Identify what “free,” “no added” or “zero” modifies and look for a qualifier in smaller type. Second, check whether another ingredient appears to serve the same sweetening, coloring, thickening or preserving function.

Third, use ingredient order to understand the broad composition without treating the order as a safety ranking. Fourth, read the nutrition, allergen, storage and date information that addresses issues the marketing claim does not cover. Fifth, check the regulator's definition in the country of sale when the claim affects a purchase decision, especially for imported foods and supplements.

Codex offers a common baseline, not a universal enforcement code. APPI News did not verify the legal definition of “natural,” “additive-free” or “zero” in every market at the time of writing. A compliant claim in one country may require different wording, evidence or thresholds in another.

Frequently asked questions

Does “natural” mean a food has been certified?
No universal Codex certification follows from that word alone. Codex guidance says use of “natural” should follow national practice in the country where the food is sold.

Does “no added sugar” mean sugar-free?
Not necessarily. It is an absence claim about what was added, while the food may contain sugars from ingredients or use a different sweetening substance. The exact definition and any threshold depend on the market's rules.

Are approved food additives automatically harmful?
No. WHO says international and national bodies assess additives and authorities authorize uses at specified levels for particular foods. A label should be assessed against those conditions, not by treating every additive as equally risky.

Is an ingredient list complete?
It is the main record of ingredients in a packaged food, but Codex provides exemptions for some processing aids and carried-over additives that no longer perform a technological function. National labeling rules can add or modify requirements.

Detox and alkaline claims lack evidence while keto needs care

APPI News Editorial — Sat, 08 Aug 2026 12:00:00 GMT

Evidence reviews do not support commercial detox programs for removing toxins or alkaline diets for preventing or treating cancer. Ketogenic diets require a different assessment: they have an established role in epilepsy care, while their weight-loss effects, risks and monitoring needs vary by protocol and patient group.

The three labels also describe very different things. “Detox” may mean fasting, juice-only diets, supplements, laxatives or colon irrigation; an alkaline diet classifies food by its proposed acid load; and a ketogenic diet sharply restricts carbohydrate to produce ketones. Treating all three as equally false, or equally safe, obscures the evidence.

When symptoms need urgent care

Stop a cleanse or restrictive diet and seek urgent medical care for confusion, difficulty breathing, unusual drowsiness, a fast heartbeat, or dizziness on standing that does not resolve. The United Kingdom's National Health Service lists these as warning signs of serious dehydration or shock. Persistent vomiting, diarrhea or an inability to keep fluids down also warrants prompt clinical assessment because fluid and electrolyte losses can worsen quickly.

Children, pregnant or breastfeeding people, older adults, and people with diabetes, kidney or heart disease should talk to a clinician before attempting a cleanse or ketogenic diet. The same applies to anyone taking prescription medicines, because a major dietary change can alter nutrition needs, glucose control or medication management.

Detox is a marketing label, not one tested treatment

The US National Institutes of Health says the liver breaks down potentially harmful substances and clears toxins, while the kidneys filter blood and remove wastes, excess water and acid. The US National Institute of Diabetes and Digestive and Kidney Diseases says healthy kidneys remove wastes and extra fluid and maintain the balance of water, salts and minerals in blood. A commercial product must therefore show what substance it removes, how that removal is measured and whether the change improves health; the word “toxin” alone does not answer those questions.

The US National Center for Complementary and Integrative Health (NCCIH) says studies of detox programs in people are few and generally low quality, and a 2015 review found no compelling evidence for toxin elimination or weight management. The center also says no studies have established the programs' long-term effects. Any early weight change on a very low-calorie program may reverse after normal eating resumes.

The risks depend on the method. NCCIH reports that laxative-based programs can cause diarrhea, dehydration and malabsorption, while consuming large amounts of water or herbal tea without food can produce dangerous electrolyte imbalances. It also warns that unpasteurized juices can cause serious illness, especially in children, older people and those with weakened immune systems.

A precise claim is easier to assess than a broad promise. Marketing should identify the substance, the test used to measure it, the size and duration of any benefit, the population studied and adverse events. Testimonials, a temporary change on the scale and more frequent bowel movements do not establish that a product removed a harmful substance.

Alkaline food does not meaningfully reset blood pH

Food can change urine pH, but that does not show that it has “alkalized” the body. The lungs and kidneys regulate acid-base balance, and a meaningful departure in blood pH is a medical problem rather than a wellness target. Urine test strips therefore cannot demonstrate that an alkaline diet has prevented disease.

A 2016 systematic review found that dietary interventions changed urine pH much more than blood pH and concluded that promoting alkaline diets or alkaline water for cancer prevention or treatment was not justified. The authors screened 8,278 citations but found only one eligible observational cancer study and no randomized trials of alkaline diets or water for cancer treatment.

The limits of that review matter. It documented a lack of supporting clinical evidence; it did not test every food pattern against every health outcome. A diet rich in vegetables, fruit and legumes may still be nutritious, but benefits from those foods should not be attributed to changing blood pH without evidence.

Ketogenic diets have medical uses and medical constraints

A ketogenic diet is not inherently pseudoscientific. The International League Against Epilepsy describes it as a carefully controlled, high-fat, low-carbohydrate treatment, typically considered when antiseizure medicines have not controlled seizures. Its clinical guidance calls for dietary supervision and periodic monitoring of electrolytes, kidney and liver function, growth and nutritional status.

That medical use does not validate every commercial keto claim. A 2023 umbrella review of randomized-trial meta-analyses found moderate-quality evidence for short-term weight and blood-sugar changes in some groups, but most associations had low or very low certainty. The authors called for longer follow-up to determine effects on cardiovascular events and mortality.

Possible adverse effects reported by the epilepsy organization include vomiting, constipation, kidney stones, high blood cholesterol, impaired growth and bone fractures. Clinical ketogenic diets may also require vitamin and mineral supplementation selected by the treatment team. These monitoring needs are one reason an epilepsy protocol should not be copied from a weight-loss menu online.

Children using a ketogenic diet for epilepsy need a specialist team. Pregnant or breastfeeding people and those with diabetes, kidney or liver disease, a history of kidney stones, or prescription medicines should discuss a major carbohydrate restriction with a clinician who knows their history. A plan used to manage epilepsy should be started, adjusted or stopped on that team's judgment.

How to assess a health-marketing claim

Start with the promised outcome. A claim such as “removes toxins” should name the substance and report a validated measurement before and after the intervention. A claim about disease prevention or weight loss should identify the study population, comparison group, duration, effect size and adverse events.

Then check whether the evidence matches the product. Research on a hospital-supervised ketogenic therapy does not establish the safety of a consumer diet plan. Evidence that vegetables are part of a healthy dietary pattern does not show that alkaline water changes blood pH, and a short calorie-restricted cleanse does not establish toxin removal.

Regulation and product availability vary by country, particularly for supplements and colon-cleansing devices. A label, seller certification or customer review is not a clinical trial. APPI News could not find published global data on how many people experience harm from commercial detox or cleansing programs at the time of writing.

Frequently asked questions

Do detox drinks remove toxins?
Published human evidence does not establish that commercial detox programs remove toxins. The claim needs to name the substance, provide a valid measurement and show a health benefit, while accounting for adverse effects.

Can alkaline water prevent cancer?
The cited systematic review found no basis for promoting alkaline water or an alkaline diet for cancer prevention or treatment. Diet can affect urine pH without meaningfully changing blood pH.

Is a ketogenic diet pseudoscience?
No. It is an established treatment for some people with epilepsy. Claims about weight loss or other conditions require separate evidence, and the diet's restrictions and monitoring needs differ by purpose and patient group.

Who should seek clinical advice before a cleanse or keto diet?
Children, pregnant or breastfeeding people, older adults, people with chronic conditions and anyone taking prescription medicine should speak with a clinician before making a major restrictive dietary change.

Adult orthodontics requires diagnosis before braces or aligners

APPI News Editorial — Fri, 07 Aug 2026 12:00:00 GMT

Adults can undergo orthodontic treatment, but appliance choice depends on the condition of the teeth, gums, roots and jaws rather than age alone. Fixed braces and clear aligners move teeth through controlled force, and both require a diagnosis, a treatment plan and follow-up care.

Clear aligners are removable plastic trays made in a sequence, while fixed appliances use brackets and archwires attached to the teeth. Appearance and convenience may influence the choice, but they do not establish which appliance can safely produce the required movement.

An examination comes before the appliance

A consultation should assess the bite, teeth, gums and supporting bone before treatment begins. The American Association of Orthodontists says an in-person examination can assess gum health, while X-rays can show roots and impacted teeth that photographs and digital scans cannot reveal. These findings can affect whether treatment starts, which appliance is used and whether another dental problem needs attention first.

Adults with active gum disease or reduced periodontal support need coordinated assessment rather than an appliance selected from photographs. The clinical findings may change the timing of treatment, the force applied and the follow-up plan.

When dental symptoms need urgent care

Seek emergency medical care for severe swelling of the mouth, lips, throat or neck that affects breathing, heavy mouth bleeding that will not stop, or a serious injury to the face or jaw. The United Kingdom's National Health Service lists those signs as reasons for immediate emergency care. A knocked-out tooth, worsening mouth swelling, or severe pain that disrupts sleep or daily activity requires urgent dental assessment.

After braces are fitted or adjusted, short-lived soreness can occur. The United Kingdom's National Health Service advises contacting the orthodontist when pain lasts more than a few days, gums become very red, swollen or painful, or braces break. Treatment should not be continued from a seller's automated schedule while a new symptom remains unassessed.

Clear aligners and fixed braces do not fit every case equally

A 2025 systematic review included 21 randomized trials and 970 patients and found no difference between clear aligners and fixed appliances on several objective grading measures. Both approaches worked for simple malocclusions treated without extractions.

The review did not establish that aligners work as well for every complex movement. The authors rated the overall evidence as low quality and called for better studies of complex malocclusions. Differences in study design and outcome reporting also prevented a clear quantitative conclusion across all treatment effects.

Metal, ceramic and self-ligating braces are all fixed appliances. Clear trays can be removed for eating and cleaning, but their performance depends partly on wear and on whether the prescribed movement is predictable with that system. The diagnosis, not the visibility of the appliance, should determine the options offered.

Gum disease changes the treatment plan

Orthodontic force acts through the tissues supporting each tooth, so periodontal status matters before and during treatment. A systematic review and meta-analysis found no material worsening of periodontal outcomes in stable, treated periodontitis patients who underwent orthodontic tooth movement, but the authors based that conclusion on a small set of low-quality studies with high risk of bias.

That finding applies to treated, stable disease, not untreated inflammation or unexplained tooth mobility. Adults may need periodontal care before orthodontic movement and monitoring during treatment. Evidence does not support promising that straightening teeth will itself prevent future gum disease.

Mail-order aligners remove clinical safeguards

Direct-to-consumer aligner services differ from dentist-supervised aligner treatment when they start tooth movement without an in-person examination, diagnostic imaging or continuing clinical review. A scan or home impression records tooth surfaces; it does not by itself assess periodontal pockets, root condition or the bone supporting the teeth.

Researchers reviewing the US Food and Drug Administration's Manufacturer and User Facility Device Experience database identified 104 reports involving direct-to-consumer sequential aligners without dentist supervision from 2010 through 2020. Bite problems appeared in 41.3 percent of the reports, orofacial pain in 29.8 percent and periodontal consequences in 26.6 percent; 69.2 percent recorded follow-up with a dental provider.

Those figures describe submitted US reports, not the risk faced by every user. The database does not provide the total number of people who used the products, reporting is incomplete, and a report does not by itself prove that an aligner caused the event. The pattern still shows why symptoms and bite changes require clinical examination rather than remote troubleshooting alone.

Whether an aligner is a regulated medical device, who may prescribe it and what remote care is permitted vary by country. A consumer should be able to identify the licensed clinician responsible for diagnosis and follow-up, understand how urgent problems will be handled and receive a written treatment and retention plan. APPI News did not verify the regulatory status of mail-order aligner services in every market.

Retention is part of treatment

Teeth can move after active orthodontic treatment, so clinicians use fixed or removable retainers to limit relapse. A 2023 Cochrane review included 47 studies with 4,377 adults and children but rated the evidence comparing retention approaches as low or very low certainty. Most studies followed patients for less than one year, and the review excluded treatment performed with aligners.

The review could not identify one best retainer or wear schedule. A fixed retainer can detach, and a removable retainer can be lost, damaged or left unworn. Patients need instructions for their own device and a route to obtain a review if it breaks, stops fitting or the teeth begin to shift.

What to establish before treatment starts

A written plan should state the diagnosis, treatment goals, proposed appliance, expected follow-up and retention arrangements. It should also explain foreseeable limitations, what could change the plan and who will examine new pain, gum changes or an altered bite.

Prices, insurance coverage and professional titles cannot be compared reliably without naming a country and a specific plan. Quotes may include different records, procedures, follow-up visits, refinements and retainers. Comparing only the advertised appliance price can therefore compare different packages of care.

Frequently asked questions

Is there an upper age limit for braces or clear aligners?
Age alone does not rule out orthodontic treatment in adults. The condition of the gums, teeth, roots and supporting bone determines whether treatment can start and what monitoring is needed.

Are clear aligners as effective as fixed braces?
Some studies report similar objective outcomes, but the evidence does not cover every movement or complex case. Extraction needs, jaw relationships, periodontal condition and the required tooth movements can change the choice.

Can photographs or a 3D scan replace an in-person examination?
No. They cannot fully assess gum pockets, tooth roots, impacted teeth or supporting bone. An examination and appropriate diagnostic records are needed before teeth are moved.

Are mail-order aligners legal?
The answer depends on the country, the device and how dental practice is regulated there. Regulatory status should be checked with the named national authority, and legal sale does not replace diagnosis or clinical follow-up.

Is a retainer needed after treatment?
Retention is used because teeth can move after braces or aligners. Evidence does not identify one best retainer or universal wear schedule, so the treating clinician should provide instructions for the device and case.

Root canal teeth can decay again and may need protective crowns

APPI News Editorial — Thu, 06 Aug 2026 12:00:00 GMT

Root canal treatment removes inflamed or infected pulp, cleans and seals the canals, and preserves the outer tooth. It does not make the tooth immune to new decay, cracks or failure of the filling or crown.

The final repair may be a filling, a partial-coverage restoration or a crown. The choice depends on the tooth's position, the amount of sound structure that remains and the forces it must withstand.

What the procedure does

The pulp is soft tissue inside a tooth that contains nerves, blood vessels and connective tissue. Deep decay, a crack, trauma or earlier dental work can leave it inflamed or infected. The American Association of Endodontists describes root canal treatment as removing that pulp, cleaning and disinfecting the inside of the tooth, then filling and sealing the canals.

A dentist then closes and restores the tooth so it can function. The United Kingdom's National Health Service says treatment commonly takes two or more appointments, may involve a temporary filling between visits, and may require a crown when a tooth was badly infected. The number and length of appointments depend on the tooth and the complexity of its canals.

When dental symptoms need urgent care

Severe tooth or mouth pain that disrupts sleep or daily activity, pain that persists despite pain relief, an enlarging swelling or lump, a knocked-out tooth, or a broken or loose filling or crown needs urgent dental assessment. The United Kingdom's National Health Service lists these as reasons to seek urgent or emergency dental care.

Heavy bleeding that will not stop, a serious injury to the face or jaw, or severe swelling of the mouth, lips, throat or neck that affects breathing requires emergency medical care. Children, pregnant people, those with chronic conditions and anyone taking medicines should tell the treating clinician about their circumstances before treatment. Their imaging, anesthesia, medication and follow-up decisions need an individual review rather than instructions intended for a general adult.

A treated tooth can decay or become infected again

Removing the pulp does not remove the enamel and dentin exposed to the mouth. Plaque can still cause decay around a filling or crown margin, and a crack can open a route for bacteria. Reduced sensitivity inside the tooth also means that pain alone is not a reliable way to judge whether the restoration remains sound.

The American Association of Endodontists identifies new decay, a loose or broken restoration, delayed crown placement, salivary contamination and previously undetected canal anatomy as reasons a treated tooth may need further care. Retreatment can sometimes preserve the tooth, but a fracture or loss of too much structure may make repair impossible.

A crown is not automatic for every tooth

Teeth that need root canal treatment often have already lost structure to decay, cracks or earlier restorations. Accessing and cleaning the canals removes more tissue. The amount and distribution of the remaining tooth structure, rather than pulp removal alone, influence the risk of fracture.

The American Association of Endodontists says molars and premolars often need crowns after root canal treatment, while front teeth may not when enough structure remains. A crown covers the tooth, but partial-coverage restorations and direct fillings can also be considered in selected cases.

A 2025 systematic review of 11 studies found better survival among root-filled teeth with indirect restorations than among those with direct restorations, but found no difference in periapical healing. Ten of the 11 studies were cohorts rather than randomized trials, and the authors said the survival finding required cautious interpretation. The evidence supports assessing the restoration, not promising that a crown will prevent every fracture or failure.

Survival figures need careful reading

A 2004 analysis of US insurance records covered 1,462,936 teeth and found that 97 percent remained in the mouth eight years after initial nonsurgical root canal treatment. Most extractions occurred within three years, and 85 percent of the extracted teeth had no full-coverage restoration.

Those numbers show an association, not proof that the absence of a crown caused extraction. The study measured retention rather than complete clinical and radiographic healing, and its population consisted of members of one US dental insurance plan.

A 2024 systematic review and meta-analysis of 20 studies estimated survival of root-filled molars and premolars at 91 percent after four to seven years and 87 percent after eight to 20 years. The authors identified the amount of remaining coronal tooth structure as a prognostic factor, while noting that relatively few studies evaluated that factor. These pooled estimates do not predict the outcome of an individual tooth.

Follow-up protects the work already done

A temporary restoration is not the end of treatment. The permanent restoration should be completed on the schedule set by the treating dentist, and a loose or broken filling or crown needs prompt assessment. Regular examinations can identify decay at restoration margins, cracks and changes around the root before they cause extensive damage.

Daily brushing with fluoride toothpaste and cleaning between teeth remain relevant because the outer tooth and surrounding gums are still exposed to oral bacteria. A root canal-treated tooth may have less response to temperature, but the tissues around its root can still become inflamed and painful.

Root canal treatment, retreatment or extraction

The decision depends on whether the tooth can be predictably cleaned, sealed and restored. Cracks extending into the root, inadequate remaining structure, poor bone support or persistent disease can change the options. An implant or bridge can replace a tooth that cannot be saved, but replacement is a separate treatment with its own surgery, maintenance, cost and failure risks.

A difficult canal, earlier failed treatment or suspected fracture may lead to referral to an endodontist or another appropriately trained dental clinician. Specialist titles and referral pathways differ across countries. A clinical examination and imaging are needed to compare preservation, retreatment, surgery and extraction for a particular tooth.

Frequently asked questions

Can a root canal-treated tooth get another cavity?
Yes. The enamel and dentin can decay at an exposed surface or around a filling or crown. New decay can let bacteria reach the sealed canals and may lead to retreatment or extraction.

Does every root canal-treated tooth need a crown?
No single restoration fits every case. Back teeth often need coverage because they carry high chewing forces, but the decision also depends on cracks, the size of the access cavity and how much sound tooth remains.

Does a 97 percent survival rate mean the treatment was cured?
No. In the US study, survival meant the tooth had not been extracted after eight years. It did not mean that every tooth was symptom-free or met every clinical and radiographic measure of healing.

What if a temporary filling or crown comes loose?
Contact a dental provider promptly. A loose or broken restoration can expose the tooth to saliva and bacteria, and waiting can reduce the structure available for repair.

Is extraction and an implant always a better long-term option?
No. Some teeth cannot be restored, while others can remain functional after root canal treatment and an appropriate restoration. The comparison requires an examination of the tooth, gums, supporting bone and bite.

Protein targets vary by age, exercise and kidney health

APPI News Editorial — Thu, 06 Aug 2026 05:55:28 GMT

The European Food Safety Authority (EFSA) sets a population reference intake of 0.83 grams of protein per kilogram of body weight a day for adults. That figure is a planning benchmark for generally healthy people, not a universal target for athletes, older adults with higher needs, or people with kidney disease.

Protein grams are not the same as the weight of a food. A 100-gram serving of fish, tofu or beans contains water, fat, carbohydrate and other nutrients, so its protein content must come from the food label or a reliable national food-composition database.

When symptoms need urgent care

A major drop in urine output, persistent vomiting, swelling of the feet or legs, new confusion, unusual sleepiness or breathlessness needs prompt medical assessment. The United Kingdom's National Health Service lists these as possible symptoms of acute kidney injury and advises people who suspect it to seek urgent medical help. A protein calculation cannot determine the cause of these symptoms.

People with known kidney or liver disease, diabetes, frailty, recent major illness, poor appetite or a history of an eating disorder should not start a high-protein or protein-restricted diet without clinical advice. Children, pregnant or breastfeeding people, and anyone taking prescription medicines also need guidance matched to growth, pregnancy, lactation, illness and treatment.

Start with the reference that fits the population

EFSA's dietary reference tables set the adult population reference intake at 0.83 grams per kilogram a day. Multiplying body weight in kilograms by 0.83 gives an estimate: 60 kilograms produces 49.8 grams a day, while 75 kilograms produces 62.25 grams.

This is a reference intake designed to cover the needs of nearly all healthy people in a population. It is not a minimum below which deficiency begins, and a single day's intake does not establish nutritional status. National authorities may use different terminology or values, so a locally published standard takes precedence when available.

The same EFSA opinion assigns separate age-based values to infants, children and adolescents, and extra daily amounts during pregnancy and breastfeeding. Those groups should not use the adult multiplication alone. Growth, gestational stage, total energy intake and clinical conditions all affect the calculation.

Most healthy adults can obtain protein from ordinary food

The World Health Organization says protein providing 10 to 15 percent of daily energy is generally sufficient for adults, or about 50 to 75 grams in a 2,000-calorie diet. It says protein can come from a mix of plant and animal sources and places that advice within a diet that also supplies vegetables, fruit, pulses, whole grains and appropriate fats.

Useful sources include beans, lentils, chickpeas, soy foods, nuts, seeds, eggs, dairy foods, fish, poultry and meat. The amount in a serving varies by food and preparation. Checking the protein line on a package or a national food database is more accurate than treating every egg, glass of milk or piece of tofu as interchangeable.

Adding a powder or bar is not required merely because a daily target has been calculated. Supplements can add calories or displace foods that provide fiber and micronutrients. Product composition, labeling and availability also vary by country.

Regular training raises the range

The International Society of Sports Nutrition (ISSN) says 1.4 to 2.0 grams per kilogram a day is sufficient for building and maintaining muscle in most exercising people. For an 80-kilogram adult, that range is 112 to 160 grams a day.

The position statement says the appropriate point within the range depends on training volume, age, body composition, total energy intake and training status. It also discusses higher intakes during an energy deficit in resistance-trained people, but that narrower use should not be presented as a target for anyone seeking weight loss.

ISSN reports that general per-meal recommendations for athletes are about 0.25 grams per kilogram, or 20 to 40 grams of high-quality protein, with feedings spread through the day. This is an exercise-nutrition framework, not evidence that every healthy adult needs a fixed protein dose at each meal.

Older adults have a separate evidence base

The PROT-AGE Study Group recommends 1.0 to 1.2 grams per kilogram a day for healthy adults older than 65. The group advises at least 1.2 grams per kilogram for older people who exercise and 1.2 to 1.5 grams for many with acute or chronic illness.

Those upper ranges do not apply automatically when kidney function is impaired. Poor appetite, unintended weight loss, frailty and sarcopenia can also make an aggressive restriction harmful if it reduces energy intake. An older person with any of these factors needs assessment of the whole diet and health status, not a protein number in isolation.

Chronic kidney disease changes the calculation

Kidney Disease: Improving Global Outcomes (KDIGO) suggests 0.8 grams per kilogram a day for adults with stage G3 to G5 chronic kidney disease and advises those at risk of progression to avoid intake above 1.3 grams per kilogram. The 2024 guideline calls for a renal dietitian or other accredited nutrition professional to tailor protein, sodium, phosphorus and potassium advice to disease severity and other conditions.

KDIGO allows a very-low-protein diet only for selected adults at risk of kidney failure who are willing and able to follow it under close supervision, with specified amino-acid or ketoacid supplementation. It says not to prescribe low or very-low-protein diets to metabolically unstable people and not to restrict protein in children with chronic kidney disease because of the risk to growth.

Dialysis changes nutrient losses and treatment goals, so the nondialysis G3 to G5 figure cannot be carried over. A dialysis team should set the target. The same caution applies when kidney disease coexists with diabetes, frailty, sarcopenia or undernutrition.

Higher intake has not been proved safe for a lifetime

A 2018 systematic review and meta-analysis of 28 articles involving 1,358 adults found no difference in changes in glomerular filtration rate between higher- and lower- or normal-protein diets in people without kidney disease. Higher-protein diets in the review provided at least 1.5 grams per kilogram, at least 100 grams a day or at least 20 percent of energy.

The finding does not establish that a particular high intake is harmless for decades. Trials were generally short, definitions of a high-protein diet varied, and another systematic review cited by the authors rated much of the available evidence at moderate to high risk of bias. Evidence from healthy trial participants also cannot be transferred to people with diagnosed or unrecognized kidney impairment.

A defensible reading is narrower than the claim that protein either inevitably damages healthy kidneys or can be increased without limit. Healthy adults in the analyzed trials did not show worse filtration changes, while KDIGO separately advises limits for chronic kidney disease. Anyone considering a sustained intake far above a general or sports reference should first establish whether a medical condition changes the risk.

How to calculate and check a daily total

First select a reference for the correct group, then multiply the stated grams per kilogram by body weight in kilograms. Add the protein listed for each food and drink across the day. Keep the unrounded calculation for planning, but treat the result as an estimate because serving size and food composition vary.

A calculation should be checked against the rest of the diet. Meeting a protein number while crowding out vegetables, fruit, whole grains or adequate energy does not meet the WHO description of a diverse, balanced diet. Plant and animal foods can both contribute, and the appropriate mix depends on local food access, culture, nutrient needs and medical constraints.

Frequently asked questions

How much protein does a healthy adult need?
EFSA's population reference is 0.83 grams per kilogram a day. A 60-kilogram adult would calculate about 50 grams, but national standards and individual circumstances can differ.

Does an athlete need more?
ISSN places most exercising people at 1.4 to 2.0 grams per kilogram a day. The suitable point depends on the sport, training load, total energy intake, age and goals.

Should older adults use the general adult figure?
Not always. PROT-AGE recommends 1.0 to 1.2 grams per kilogram for healthy adults older than 65, with higher ranges for some active or ill older people. Kidney disease, frailty and undernutrition require an individualized assessment.

Do high-protein diets damage healthy kidneys?
The cited 2018 meta-analysis did not find worse changes in filtration among healthy adults eating higher-protein diets, but the evidence was not long enough to prove lifetime safety. People with chronic kidney disease have different targets.

Can someone with chronic kidney disease use an online formula?
Not as a stand-alone plan. KDIGO's 0.8-gram figure applies to adults with G3 to G5 chronic kidney disease who are not covered by reasons for a different target, and the guideline calls for advice tailored to disease severity and other conditions.

WHO guidance sets limits on cooling bedrooms during hot nights

APPI News Editorial — Thu, 06 Aug 2026 05:55:28 GMT

The World Health Organization (WHO) advises moving to the coolest room at night and using air conditioning with a fan when available during a heatwave. Fans, bathing and bedding serve different purposes, and no single bedroom temperature suits every sleeper or climate.

Sleep and body temperature are closely linked. A review in Current Opinion in Physiology reports that core temperature falls during the transition to non-rapid eye movement sleep, while heat loss through the skin helps create the temperature gradient associated with sleep onset. Feeling cold at one patch of skin is therefore not evidence that a product has cooled the body as a whole or improved sleep.

Heat illness needs urgent care

Difficulty sleeping can be an early practical problem during a hot night, but faintness, dizziness, nausea, confusion, loss of consciousness or stopping sweating can signal a medical emergency. WHO says emergency medical help should be called immediately for suspected heatstroke and cooling should begin while help is on the way.

Move the person to shade or an air-conditioned place, loosen unnecessary clothing and apply cold, wet cloths while waiting for emergency services. WHO also says heat cramps lasting more than one hour need medical attention; symptoms that persist after moving to a cool place also require clinical advice.

Infants and children, adults older than 60, and people with heart, lung or kidney conditions need closer checks during a heatwave. People with chronic disease who take daily medicines should not change or stop treatment based on general cooling advice, because heat and dehydration can alter individual risks. Pregnant people should keep cool and contact their pregnancy care provider if fetal movement is lower than usual; WHO's European office identifies reduced fetal movement as a reason to contact a midwife or pregnancy care provider.

Cool the room before relying on skin sensation

WHO advises opening windows after dark when outdoor air is cooler than indoor air, then closing windows and blocking direct sunlight during the day when it is hotter outside. Electrical devices that are not needed can be switched off because they add heat indoors. If a home cannot be kept cool, WHO advises spending two to three hours in a cool place during the day.

For homes with air conditioning, WHO gives a heatwave setting of 27 degrees Celsius with a fan. The figure is a public-health measure for limiting indoor heat, not a universal prescription for sleep. Humidity, airflow, bedding, clothing, building design, health and acclimatization all affect how the same thermostat setting feels.

Light, loose bed linens can reduce heat accumulation. There is not enough evidence in the sources reviewed here to rank cotton, linen, synthetic cooling fabrics, mats or pillows by their effect on core temperature or sleep. A cool sensation from a pillow or sheet may improve comfort, but product claims should not be treated as proof of a measurable sleep benefit.

Fans have a heat limit

Fans move air and can increase sweat evaporation, but they do not lower room temperature. WHO says fans may provide relief when indoor temperature is above 35 degrees Celsius but may not prevent heat-related illness, and it advises using them only below 40 degrees Celsius because hotter air can heat the body.

That distinction matters on nights when a room remains extremely hot. A fan can be paired with air conditioning, used to draw in cooler outdoor air after dark, or used with damp cloths and wet skin as WHO describes. It should not delay moving to a cooler place or seeking help when warning signs appear.

Warm bathing has limited evidence for sleep onset

A 2019 systematic review in Sleep Medicine Reviews found that a warm bath or shower at 40 to 42.5 degrees Celsius was associated with better self-rated sleep quality and sleep efficiency. Bathing one to two hours before bed, for as little as 10 minutes, was also associated with a shorter time to fall asleep.

The timing result was not supported by a large clinical evidence base. The review identified 17 eligible studies and used comparable quantitative data from 13, while its conclusion about the one-to-two-hour window relied on two studies totaling 36 participants. The evidence does not show that hotter or longer bathing produces a larger benefit.

A cool shower has a different purpose during extreme heat: it can help remove heat from the body at that moment. WHO includes cool showers and baths in its heatwave advice. The reviewed evidence does not support a broad claim that every cold shower before bed worsens sleep, so water temperature can be chosen for immediate heat relief without assuming a proven sleep effect.

A practical sequence for a hot night

Start with the room: block daytime sun, release heat after dark only when outdoor air is cooler, and use air conditioning with a fan when available. Keep bedding light, move to the coolest room and check the indoor temperature rather than relying only on how the skin feels.

A fan remains a comfort tool, not protection from heat illness at every temperature. Warm bathing one to two hours before bed has some evidence for shortening sleep onset, while cool bathing can provide immediate heat relief. Neither replaces a cooler environment when indoor heat remains unsafe.

Frequently asked questions

Should windows stay open all night?
Open windows when outdoor air is cooler than indoor air and the opening is safe. Close them when the air outside is hotter, and use blinds or shutters to reduce daytime heat gain.

Is 27 degrees Celsius the best sleep temperature?
No universal optimum has been established. WHO's 27-degree setting with a fan is heatwave guidance for air-conditioned homes, not a sleep prescription for every person or country.

Can a fan protect someone during extreme indoor heat?
Not reliably. WHO says a fan may not prevent heat-related illness above 35 degrees Celsius and can heat the body above 40 degrees Celsius.

Does a cooling pillow lower core temperature?
The sources reviewed for this report do not establish that claim. A cooling surface may feel comfortable locally, but that is different from measured whole-body cooling or improved sleep.

Humanoid robot tested in two pig surgeries under remote control

APPI News Editorial — Thu, 06 Aug 2026 05:55:28 GMT

University of California San Diego researchers reported on July 8, 2026, that a surgeon remotely controlled a humanoid robot during two laparoscopic gallbladder operations on pigs. The peer-reviewed Nature paper describes the work as an in vivo feasibility study using teleoperation, benchtop tests and dry-laboratory comparisons.

The robot did not choose the surgical plan or act independently. A senior surgeon operated it from a console, and human clinicians carried out most bedside assistance in both procedures.

What the humanoid system did

The researchers built the system around the G1, a general-purpose humanoid made by China-based Unitree Robotics, and adapted it to hold wristed laparoscopic instruments. The console sent the surgeon's hand commands to the robot over a network, while a stereo camera supplied the operative view. The robot then moved the instruments through ports in the animal's abdomen.

The full study reports that attending surgeons and clinical fellows placed the abdominal ports before the robot was positioned, and a human assistant managed most camera control, tissue retraction, exposure and instrument adjustments. A second humanoid briefly held the camera and retracted tissue during the first case, but it did not replace the bedside team.

Both operations followed the established steps of laparoscopic cholecystectomy, or gallbladder removal. The robot-compatible equipment did not include a clip applier, so clinicians clipped the cystic duct and tied off the cystic artery with conventional laparoscopic methods before robotic work resumed.

The 32-minute figure covers console time

The first case recorded 56 minutes 15 seconds of active console control. The second recorded 31 minutes 59 seconds, commonly rounded to 32 minutes. These were not total procedure times: the study separated periods when the surgeon actively moved the humanoid from pauses for camera cleaning, instrument changes, recalibration and repositioning.

The study's workflow table records eight robot deployments in the first case and four in the second, with major pauses lasting more than three minutes occurring twice and three times, respectively. The second operation also involved minor bile leakage and bleeding from the liver bed, which the team managed with suction and electrocautery. Neither case required conversion to conventional laparoscopy or open surgery.

How it differs from the da Vinci system

The humanoid and Intuitive Surgical's da Vinci platform share one basic feature: a surgeon controls the instruments from a console. Intuitive Surgical's system guide says every surgical maneuver remains under the surgeon's direct control and that the system translates hand movements into instrument movements.

The hardware is different. Da Vinci is a purpose-built surgical platform with dedicated arms, instruments, imaging and operating-room procedures. The research system starts with a general-purpose humanoid, then adds mounts, control software and laparoscopic equipment.

The experiment does not establish that the humanoid is clinically equivalent to da Vinci. In a dry-laboratory peg-transfer task involving 13 medically trained participants, the da Vinci Xi produced faster average completion times, fewer errors and higher scores than the humanoid. The comparison tested a training exercise, not patient outcomes.

Why this is not autonomous surgery

Teleoperation transmits a person's decisions and movements to a machine. Autonomy requires the system to make at least some decisions or carry out parts of a task without continuous manual control. The pig operations tested the former, even though the platform may support more automated functions in later research.

A 2024 systematic review screened US regulatory databases and classified 49 surgical robots cleared by the US Food and Drug Administration from 2015 through 2023 on a five-level autonomy scale. It placed 86 percent at Level 1, robot assistance, and 6 percent at Level 3, conditional autonomy. The review found no Level 4 or Level 5 systems in that set.

That review and the humanoid experiment cover different groups. The review examined surgical devices already cleared in the United States, while the humanoid paper reports a preclinical research platform tested in animals. Its results do not establish clearance, approval or clinical availability in any country.

Barriers before human use

The research team identified control latency, limited reachable workspace and sensitivity to calibration drift compared with established surgical systems. During the animal procedures, clinicians also encountered repeated repositioning, reduced strength and intermittent overheating. Those problems raised the workload for the surgeon and bedside team.

Sterility is another unresolved issue. The researchers covered the robot's arms with gloves, but said this setup did not reproduce the sterile workflow required for human surgery. Commercial humanoid components cannot generally be sterilized in an autoclave, and any protective drape would also have to preserve sensor performance and calibration.

UC San Diego's research release says the robots needed recalibration several times and that the team is still working on communication delay for longer-distance operation. The university presented remote communities and difficult field settings as possible future uses, not current clinical deployments.

APPI News could not verify a public regulatory filing or a timetable for human trials at the time of writing. Any future authorization and availability would vary by country.

Frequently asked questions

Did the humanoid robot operate autonomously?
No. A surgeon controlled the instruments from a remote console throughout the robotic portions of both procedures. Human clinicians also placed ports, performed steps that lacked compatible robotic tools and provided most bedside assistance.

Did a humanoid robot complete surgery in 32 minutes?
The second case logged 31 minutes 59 seconds of active console control. That measurement excluded pauses and should not be read as the total time spent in the operating room.

Was the system tested on people?
No. The paper reports two operations on pigs in a surgical simulation center. It does not report a human trial or routine clinical use.

Is the humanoid system equivalent to da Vinci?
No such equivalence has been demonstrated. Both are controlled from a surgeon's console, but they use different hardware, and the established da Vinci Xi outperformed the humanoid in the study's dry-laboratory peg-transfer comparison.

Brief pain from cold drinks may signal exposed dentin, not decay

APPI News Editorial — Wed, 05 Aug 2026 12:00:00 GMT

A short, sharp pain after a cold drink may come from exposed dentin, but the symptom alone cannot rule out decay, a cracked tooth or inflammation inside the tooth. Dentin hypersensitivity is diagnosed only after other dental causes have been considered.

The pain commonly follows cold, heat, touch, air or sweet and acidic foods, then fades when the stimulus ends. Pain that continues, starts without a trigger or occurs during biting needs a different level of assessment.

When tooth pain needs prompt care

Dental assessment should not be delayed when pain lingers for minutes after heat or cold is removed, starts spontaneously, wakes someone from sleep or makes it hard to identify the affected tooth. Merck Manual distinguishes pain that stops within one or two seconds after a cold or sweet stimulus from pain that occurs spontaneously or persists for minutes, which can accompany irreversible pulpitis. Sharp pain on biting, a broken tooth or filling, fever, a bad taste, or swelling of the cheek or jaw also calls for dental review.

The United Kingdom's National Health Service advises dental care for toothache lasting more than two days, pain on biting, fever, red gums, a bad taste or swelling of the cheek or jaw. Swelling around the eye or neck, or swelling that interferes with breathing, swallowing or speaking, requires emergency medical care.

Children with dental pain need age-appropriate assessment rather than adult self-care instructions. Pregnant people, those with chronic conditions and anyone taking medicines should tell a dentist or other clinician about those circumstances before treatment or medication decisions are made.

Exposed dentin changes how a tooth responds

Enamel covers the crown of a tooth, while cementum covers its root. Dentin lies beneath those surfaces and contains microscopic tubules that run toward the pulp, the soft inner tissue containing nerves and blood vessels. Gum recession, loss of enamel or wear at the neck of a tooth can expose the tubules to the mouth.

A systematic review describes fluid movement through exposed dentinal tubules as the leading explanation for dentin hypersensitivity and says the diagnosis requires exclusion of other dental and periodontal conditions. Cold, heat, air, touch or changes in concentration can shift that fluid and activate pain near the pulp. Decay, cracked teeth, damaged restorations and pulp disorders can produce overlapping symptoms.

Exposure can follow gum recession, periodontal disease, acidic erosion, tooth wear or an abrasive brushing pattern. These causes are not interchangeable: erosion, gum disease, grinding and a damaged restoration require different clinical decisions. A dental examination can identify the exposed surface and check for another source of pain.

Prevalence estimates depend on how sensitivity is measured

A 2019 systematic review and meta-analysis of 77 studies reported a pooled best estimate of 11.5 percent for dentin hypersensitivity. Individual estimates ranged from 1.3 percent to 92.1 percent.

The authors linked some of that variation to the participants' ages, recruitment methods, study settings and the number of sites involved. Specialty-practice samples produced higher estimates than some broader populations. The pooled figure shows that the complaint is common, but it cannot determine whether a particular episode of pain is dentin hypersensitivity.

Desensitizing toothpastes use two broad approaches

Desensitizing toothpastes generally try to reduce fluid movement by blocking tubules or to reduce nerve excitability. A 2022 scoping review of 138 randomized trials identified arginine, calcium sodium phosphosilicate and stannous fluoride among tubule-occluding ingredients, while potassium compounds act on pulpal nerve excitability. Formulations differ, so the active ingredient on a label carries more information than a general sensitivity claim.

A 2020 network meta-analysis included 125 randomized trials with 12,541 patients and found that results varied by ingredient and whether pain was tested with touch, cold or air. Calcium sodium phosphosilicate showed benefit across all three stimuli with high- to moderate-certainty evidence. Stannous fluoride and some combinations containing potassium performed well for touch and air, while arginine showed benefit for air and potassium or strontium for touch.

Those comparisons do not establish one universal best toothpaste. Trials used different formulations and pain scales, and a group average does not guarantee relief for an individual. Continuing or worsening pain should not be managed by repeatedly changing products without checking the cause.

Daily care should protect exposed surfaces

Brushing should remove plaque without adding avoidable abrasion to exposed roots. The United Kingdom's National Health Service recommends brushing twice daily for about two minutes with fluoride toothpaste and says medium or soft bristles are best for most adults. It also advises spitting out excess toothpaste without rinsing immediately, which leaves more fluoride on the teeth.

A dentist or dental hygienist can check brushing technique when recession or wear is present. Frequent acidic exposure, tooth grinding, recent whitening and reflux symptoms may also matter, but addressing them depends on the actual cause. Professional treatment can range from applying an occluding material to restoring lost tooth structure or treating gum or pulp disease.

Frequently asked questions

Does a brief pain after a cold drink mean there is a cavity?
No single symptom can make that distinction. Brief pain can occur with exposed dentin, while decay, a crack, a damaged restoration and pulp inflammation can produce overlapping symptoms. A dental examination is needed when the cause is uncertain or the pain returns.

Can desensitizing toothpaste reduce the pain?
Systematic reviews report average benefits for several ingredient classes, but the result depends on the formulation and the type of stimulus. Persistent, spontaneous or worsening pain needs assessment instead of an assumption that it is simple sensitivity.

Why does pain duration matter?
Pain from cold or sweets that stops within one or two seconds can occur with reversible pulp irritation. Pain that begins without a trigger or lingers for minutes after the stimulus is removed can occur with irreversible pulpitis and requires dental evaluation.

When is swelling an emergency?
Swelling around the eye or neck, or swelling that affects breathing, swallowing or speaking, requires emergency medical care. Cheek or jaw swelling with toothache needs prompt dental assessment even when breathing is unaffected.

Partners and families can ease breastfeeding pressure after birth

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

The World Health Organization (WHO) says postnatal care should support the well-being of the parent and newborn, not focus on feeding outcomes alone. Partners and relatives can take responsibility for household and childcare work, while health workers provide practical feeding help and assess physical and mental health concerns.

A 2024 study adds a warning about the way that support is delivered. Pressure to breastfeed was associated with higher anxiety, stress and birth-trauma symptoms four weeks later among postpartum parents in New Zealand. The finding does not establish cause and effect, but it argues against treating milk supply or feeding method as a test of parenting.

Some mental-health signs require urgent action

Thoughts of suicide or of harming the baby require urgent help through local emergency or crisis services. The United Kingdom's National Health Service (NHS) lists these thoughts among symptoms of postnatal depression and says low mood, anxiety or irritability that continues beyond two weeks, worsens or becomes hard to manage should prompt a request for clinical help.

Hallucinations, delusions, severe confusion, unusually elevated or overactive behavior, or rapidly changing moods soon after birth can indicate a different emergency. The NHS says postpartum psychosis often begins suddenly within the first two weeks after birth, can worsen rapidly and needs an urgent same-day assessment. A partner or relative may need to act because the person experiencing it may not recognize that they are unwell.

Emergency numbers and routes into care vary by country. Family members should use the local emergency service if there is an immediate danger, remain with the parent and baby when it is safe to do so, and tell responders about the recent birth and the specific changes they have observed.

Pressure and support are not the same intervention

The 2024 Frontiers in Public Health study followed 225 postpartum mothers and other birthing parents living in New Zealand, using two self-report surveys about four weeks apart. Of the participants, 39.6 percent reported strong pressure to breastfeed, 17.8 percent reported shame about feeding, and 51.6 percent reported feeding-related stress.

Strong pressure at the first survey was associated with higher anxiety, stress and birth-trauma symptom scores at the follow-up. The later associations with depression and suicidal thoughts were not statistically supported. Because participants volunteered for an online survey and the analysis was observational, the results cannot show that pressure caused the symptoms or predict what will happen in other populations.

The qualitative responses described pressure from social expectations, health messaging and beliefs that breastfeeding success defined good parenting. Support begins from a different premise: the parent retains control over feeding decisions and can ask for information or practical assistance without being graded on the result.

Partners can take ownership of work around feeding

A 2020 systematic review identified seven studies that examined specific forms of partner support and breastfeeding initiation, duration or exclusivity. Four found that verbal encouragement was associated with longer duration or greater exclusivity. Other helpful actions in the included studies were responding to the breastfeeding parent's needs, helping address feeding difficulties, and taking on household and childcare duties.

The evidence base was small and mixed. Only two of the seven studies were controlled clinical trials; the others included a prospective cohort, three cross-sectional studies and a qualitative study. The review's authors called for stronger population and intervention research, so the findings support a menu of practical actions rather than a guarantee that any one task will extend breastfeeding.

Partners can change diapers, settle and burp the baby, prepare food and water, wash feeding equipment when it is used, manage laundry and visitors, and take responsibility for other children. The useful division depends on how the baby is fed, whether expressed milk or formula is involved, available leave, disability, household structure and the parent's stated needs. Asking what task should be taken over is more informative than repeatedly asking how much milk the baby received.

Health services have a separate role

WHO recommends practical support to help parents initiate and establish breastfeeding, manage common difficulties, express milk during temporary separation and recognize an infant's feeding cues. Pain, concerns about attachment or positioning, or uncertainty about whether an infant is feeding effectively are matters for a trained health worker, not problems relatives should diagnose at home.

WHO's 2022 postnatal guideline defines a positive experience as consistent information, reassurance and support for women, newborns, partners, parents, caregivers and families. Its recommendations include breastfeeding counselling, partner involvement and screening for maternal depression and anxiety with referral and management services where needed.

Preterm or unwell infants may need a feeding plan set by their clinical team. A breastfeeding parent who is pregnant again, has a chronic condition or takes prescription medicine also needs advice matched to that condition and the medicine involved. Family members should help the parent reach an appropriate clinician rather than recommend supplements, change medicines or set a feeding target themselves.

Relatives can lower the social pressure

Questions about milk volume, exclusivity or the baby's weight can sound like an assessment when they are repeated or paired with comparisons. A more useful visit starts with a concrete offer: prepare a meal, refill water, wash dishes, handle laundry or watch the baby while the parent rests. Concerns about growth or intake should be taken to the baby's clinician and assessed with the relevant clinical information.

Families can also protect time for sleep and limit visitors if that is what the parent wants. Support should continue if feeding changes to expressed milk, combination feeding or formula. The practical goal is a fed infant and a parent whose physical recovery, mental health and choices remain part of postnatal care.

Frequently asked questions

Does partner support guarantee longer breastfeeding?
No. The cited systematic review found generally favorable associations, but it included only seven studies with varied designs and only two controlled trials. Feeding outcomes also depend on health, infant needs, access to care, work and personal choice.

What is the difference between encouragement and pressure?
Encouragement respects the parent's decision and responds to a stated need. Pressure ties approval to a feeding outcome, repeats unwanted questions or withholds support when the feeding plan changes.

When should low mood prompt clinical help?
The NHS says mood changes commonly called the “baby blues” usually resolve within two weeks. Low mood, anxiety or irritability that persists, worsens or makes coping difficult should be discussed with a qualified health professional; thoughts of self-harm or harming the baby require urgent help.

Who should assess breastfeeding pain or concern about milk intake?
A trained health worker should assess the parent and baby. Relatives can arrange transport, attend appointments if invited, record questions and take over household work, but they should not diagnose the cause or set a treatment plan.

Food poisoning warning signs include dehydration and bloody diarrhea

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

The World Health Organization (WHO) said in a June 2026 update that unsafe food causes an estimated 866 million illnesses and 1.52 million deaths worldwide each year. WHO lists nausea, vomiting, abdominal pain, diarrhea, fever and headache among the symptoms associated with major foodborne infections.

Those symptoms do not prove that food caused an illness. Viruses spread from another person, medication side effects and urgent abdominal conditions can produce overlapping complaints, so the pattern and severity guide the next step rather than establish a diagnosis.

Symptoms may begin hours or days after exposure

Foodborne illness commonly causes diarrhea, nausea, vomiting and abdominal cramps. Fever, headache and weakness can also occur, while blood or mucus in the stool may point to a more inflammatory illness that needs clinical assessment.

The last meal is often not the source. The US Centers for Disease Control and Prevention (CDC) says symptoms often begin two to three days after contaminated food is eaten and advises recording food, restaurants and events from the previous week. Some toxin-mediated illnesses begin within hours, while some bacterial infections take days or longer.

These warning signs need prompt medical assessment

Urgent medical assessment is warranted when vomiting makes it impossible to keep liquids down, urine becomes very scant or stops, or dizziness, confusion, unusual drowsiness or marked weakness develops. Blood in the stool, severe or worsening abdominal pain, a swollen or very tender abdomen, and a high or persistent fever also require prompt care.

A child who is lethargic, cannot drink, drinks poorly or has markedly reduced urination needs urgent assessment. WHO identifies dehydration as the main immediate threat from diarrhea and advises consulting a health professional when diarrhea persists, blood appears in the stool or signs of dehydration develop.

Severe, localized or rebound abdominal tenderness can signal a problem other than uncomplicated gastroenteritis. A 2025 adult acute-gastroenteritis review in the Singapore Medical Journal identifies severe dehydration, signs of a surgical abdomen and high-risk patient characteristics as red flags for further evaluation or hospital care.

Fluids come before attempts to stop diarrhea

People who remain alert and can drink should replace lost fluid and salts. Oral rehydration solution is formulated with water, glucose and electrolytes for that purpose; small, repeated sips may be easier to tolerate when nausea is present. Severe dehydration or shock may require intravenous fluids in a medical setting.

Urination provides a useful warning signal, though it is not a precise measure of hydration. Much less urine than usual, very dark urine, a dry mouth, intense thirst or dizziness on standing should move the decision toward clinical care, especially when fluid losses continue.

Medicines that slow bowel movement are not suitable for every episode. CDC clinical guidance says antidiarrheal medicines should be avoided when diarrhea occurs with blood in the stool or a high fever because they may worsen the illness. A clinician or pharmacist can check whether a medicine is appropriate for the symptoms, age, pregnancy status, chronic conditions and other medicines being taken.

Higher-risk groups need separate decisions

The CDC identifies children under five, pregnant people, adults aged 65 and older, and people with weakened immune systems as groups more likely to become severely ill from contaminated food. This United States guidance is consistent with the groups highlighted in WHO food-safety material, but the route into care differs by country.

Infants and children

Young children can become dehydrated quickly and should not receive adult self-care instructions. A caregiver should contact a clinician when a child has repeated vomiting or diarrhea, drinks poorly, urinates much less, becomes unusually sleepy or irritable, or has blood in the stool.

Pregnancy

Some foodborne infections can affect a pregnancy even when gastrointestinal symptoms appear mild. Pregnant people should contact a maternity or medical clinician early about fever, vomiting, diarrhea or a known exposure to recalled food rather than relying on general adult advice.

Older adults

Older adults may have less reserve during rapid fluid loss and may not notice thirst early. New confusion, weakness, dizziness or reduced urination should prompt clinical assessment rather than waiting for gastrointestinal symptoms to become severe.

Chronic illness, immune suppression and regular medicines

People with kidney, liver or heart disease, diabetes, cancer, immune suppression or other complex conditions should contact a clinician earlier because dehydration and infection can affect them differently. Regular medicines may also change what fluids or symptom-relief products are appropriate.

A written timeline can help clinicians and investigators

A useful record includes when symptoms began, how vomiting and diarrhea changed, whether fluids stayed down, and how often urination occurred. It should also cover meals, snacks, restaurants, gatherings and animal contact during the previous week, along with whether other people became ill.

Receipts, packaging and recall notices can help public-health investigators connect cases. When several people become ill after a shared meal or a recalled product may be involved, the incident can be reported to the appropriate local food-safety or public-health authority. Agency names, reporting thresholds and procedures vary by country.

Frequently asked questions

Can symptoms identify which food caused the illness?
No. Incubation periods vary, and the responsible food is often not the last thing eaten. A food and activity record from the previous week is more useful than choosing one meal based on timing alone.

When does diarrhea require medical care?
Blood in the stool, signs of dehydration, repeated vomiting that prevents drinking, altered alertness, severe abdominal pain, or a high or persistent fever call for prompt assessment. Children and higher-risk adults may need care earlier.

Should food poisoning be treated with an antidiarrheal medicine?
Not automatically. Medicines that slow the bowel can be unsafe when blood or high fever is present, and suitability also depends on age, pregnancy, health conditions and other medicines.

Which department or clinic handles suspected food poisoning?
Health systems use different names and referral routes. Local urgent-care or primary-care services can assess stable patients, while severe dehydration, confusion, inability to drink or severe abdominal pain warrants the local emergency service.

Swallowing, diapers and weight show whether a newborn gets enough milk

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

The United Kingdom's National Health Service (NHS) reviewed its breastfeeding attachment guidance in June 2026 and directs parents to what happens during and after a feed rather than to one volume measurement. Rhythmic sucking and swallowing, diaper output and weight gain provide different pieces of the intake picture.

The milk collected in one pumping session is the amount removed by that pump at that time. It is not a direct measurement of what a baby transferred during a separate breastfeed, and pump fit, settings and the timing of milk flow affect the amount collected.

Some signs require urgent medical assessment

A newborn who is difficult to wake, unusually drowsy or not responding normally needs urgent assessment, particularly if the baby is no longer interested in feeding. Breathing difficulty, grunting, very fast breathing, blue or gray lips or tongue, or a first seizure require the local emergency service.

A temperature of 38°C or higher in a baby younger than three months requires urgent medical advice. The NHS uses that age-and-temperature threshold and also identifies markedly less-wet diapers, sunken eyes and absent tears as dehydration warnings. These are United Kingdom triage criteria; parents elsewhere should use their local urgent-care or emergency route.

Feeding concerns also need prompt assessment when wet diapers remain below the age-based pattern, weight keeps falling or does not begin to recover, yellow coloring deepens, or the baby repeatedly feeds without visible or audible swallowing. One sign alone may not identify the cause, but waiting for several signs to appear can delay care.

A feed gives visible signs of milk transfer

The NHS describes effective attachment as a wide-open mouth, the chin touching the breast, a clear nose and full, rounded cheeks while the baby feeds. The NHS also says the pattern should move from a few rapid sucks to longer sucks with audible swallowing.

Pain that continues through a feed, a nipple that emerges flattened, pinched or white, hollow cheeks, repeated slipping off the breast, or no detectable swallowing calls for a feeding assessment. A trained health worker can observe positioning and attachment and assess both the baby and lactating parent.

Diapers show a pattern across several feeds

Urine output normally rises over the first days after birth, so the baby's age matters. The NHS says a breastfed newborn will often have only two or three wet diapers in the first 48 hours, while from day five the expected pattern is at least six heavy, wet diapers every 24 hours.

The same NHS guidance expects at least two soft, yellow stools a day from day four during the first few weeks. Stool frequency can change as an infant gets older, so this early-newborn benchmark should not be applied indefinitely. Diapers that stay dry or become much less wet than the baby's recent pattern matter more than one borderline count.

Disposable diapers can make small amounts of urine hard to judge. Recording feeds, wet diapers and stools over 24 hours gives a clinician a more useful timeline than an estimate made from memory.

Weight is interpreted as a curve, not a single number

Some weight loss is expected after birth, followed by recovery. The Academy of Breastfeeding Medicine says a term newborn who loses more than 10 percent of birth weight, or has fewer than one void and stool per day of life, needs a careful breastfeeding assessment. The threshold triggers evaluation and does not establish a diagnosis on its own.

The same 2022 protocol says many newborns regain birth weight within seven to 14 days, while some take longer, especially after a cesarean birth. Clinicians interpret serial measurements alongside gestational age, birth circumstances, examination findings, feeding observations and diaper output.

Home scales can vary with clothing, diapers, time of day and device accuracy. Scheduled newborn follow-up provides measurements on a clinical growth chart and a chance to investigate a flat or falling trend.

Pump output answers a different question

A pump measures expressed volume, which is useful when that milk will be given as a feed or when a clinical team is tracking expression. It does not reproduce every condition of direct breastfeeding. Guy's and St Thomas' NHS Foundation Trust says milk may begin flowing at different stages of pumping, funnel fit must be checked and people should not compare their output with someone else's.

Repeated low expressed volumes still deserve attention when a baby depends on expressed milk, when feeds are being missed, or when the baby's diapers or weight raise concern. A clinician or lactation professional can assess pump fit, the expression schedule, the parent's health and the baby's feeding plan without treating one bottle as proof of overall supply.

Frequent feeding is not proof of low intake

The World Health Organization and UNICEF recommend breastfeeding on demand, as often as the infant wants during the day and night. Frequent or clustered feeds can therefore occur without showing that intake is inadequate.

Frequency cannot settle the question by itself. Repeated feeds without swallowing, an infant who cannot stay awake to feed, age-inappropriate diaper output or a concerning weight trend shifts the decision toward clinical assessment.

Preterm and unwell babies need an individual plan

The thresholds in the Academy of Breastfeeding Medicine protocol cited above apply to term newborns. A premature baby, an infant treated for jaundice, or a baby with another illness may have different intake targets, follow-up intervals and ways of receiving milk set by the neonatal or pediatric team.

A lactating parent who is pregnant, has a chronic condition or takes regular medicine should ask the relevant clinician before changing medicine or adopting a feeding intervention. General newborn benchmarks cannot account for the parent's condition, the infant's health and the medicine involved.

Family support can make clinical follow-up and feeding work easier without turning milk volume into a test of parenting. APPI News has separately reported how partners and relatives can take over household work while respecting the parent's feeding decisions.

Frequently asked questions

Does a soft breast mean milk supply has fallen?
No conclusion can be drawn from breast fullness alone. The baby's swallowing, diaper output, alertness and weight trend provide more relevant evidence, while persistent concern warrants a feeding assessment.

Does taking more milk after breastfeeding prove the breastfeed was inadequate?
No. One additional feed does not measure what was transferred earlier. Clinicians assess the feeding pattern, attachment, swallowing, diaper output and serial weight together.

Should parents wait for the next routine appointment if diaper counts are low?
No. They should contact the baby's clinician or local postnatal service promptly, and use urgent or emergency care when reduced output occurs with difficult waking, abnormal breathing, poor responsiveness or a fever of 38°C or higher in a baby under three months.

Can a diaper count replace a weight check?
No. Diaper output and weight describe different parts of intake and hydration. Neither identifies the cause of a feeding problem without the baby's age, examination and feeding history.

Stretchable circuits advance, but implants remain unproven

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

Researchers in South Korea and the United States reported two manufacturing advances for stretchable electronics in 2026. One kept liquid-metal conductors working under repeated strain, while the other put a dense computing array on a stretchable patch, but neither study tested a finished implant in people.

The work addresses two different parts of a soft electronic system: connections that carry signals and transistors that process them. Both could inform future wearable or implantable devices, although the published evidence remains at the component and prototype stage.

Liquid-metal paths survive repeated stretching

A Korea Advanced Institute of Science and Technology-led team reported a way to pattern liquid-metal particles on a silicon wafer and transfer the complete pattern into several polymers at cryogenic temperature. The Nature Communications paper, published on February 26, 2026, describes transfers of gallium-based liquid metals into six polymer substrates and patterned lines from 5 to 500 micrometers wide.

The particles form connected electrical paths inside the polymer after an initial stretching step breaks their oxide shells and lets neighboring particles join. The activated material reached an average conductivity of 1.71 million siemens per meter, about half the value of the bulk liquid metal used by the researchers.

The team tested lines embedded in polydimethylsiloxane through 1,000 cycles at 50 percent and 70 percent strain. Resistance changed consistently across those cycles, and the paper also reports electrical stability after six months of storage. These are laboratory measures of an interconnect material, not service-life evidence for a medical product.

The prototype links circuits to skin sensors

The liquid-metal team used the process to make a 72-element pressure-sensor array that conformed to a human hand. It also assembled a skin-mounted prototype that recorded electrocardiogram and muscle signals and tested an electrochemical glucose sensor in controlled conditions. The paper presents these demonstrations as potential wearable applications rather than validated monitoring devices.

The same process joined rigid chips to stretchable liquid-metal interconnects in a small neuromorphic circuit. That integration matters because soft conductors still have to connect with conventional components for power, sensing or computation. The experiment did not combine all of those functions into a self-contained medical patch.

A separate array performs local computing

A University of Chicago and Argonne National Laboratory team took a different route. Its Nature Electronics paper, published on May 20, 2026, reports intrinsically stretchable organic electrochemical transistor arrays with densities of up to 10,000 devices per square centimeter.

Organic electrochemical transistors use electrical current and ion movement through an electrolyte to process and retain signals. The team patterned the gel-like electrolyte with ultraviolet light, allowing a larger and denser array than earlier prototypes.

The university says the array located electrical wavefronts in mapping data from a donor human heart with 99.6 percent accuracy while stretched beyond 1.5 times its original length. The calculation ran on the array in milliseconds instead of sending data to a remote server. The result measures agreement in a hardware-computing task; it is not a clinical diagnostic accuracy figure.

The studies solve different engineering problems

The liquid-metal work focuses on fabrication and electrically stable connections across soft substrates. The organic-transistor work focuses on local computation that can deform with a patch. Neither paper shows the two technologies operating together, so their reported figures should not be treated as the specifications of one device.

The distinction also separates flexible from stretchable electronics. A flexible circuit can bend around a surface, while a stretchable circuit must tolerate changes in length and shape. Repeated deformation can alter resistance, break interfaces or loosen connections between soft and rigid components, which is why the new studies test strain alongside electrical performance.

The research is related to other early-stage medical robotics and electronics projects, where technical feasibility precedes clinical evidence. A separate APPI News report on a humanoid robot tested in two pig surgeries likewise distinguishes an engineering demonstration from an authorized clinical system.

Implant use requires evidence beyond stretch tests

A component that touches tissue must be evaluated as part of a finished device for its intended use and exposure. ISO 10993-1:2025 sets out biological-safety evaluation within a risk-management process, taking account of material composition and the nature and duration of body contact. A conductivity result or a short prototype demonstration does not answer those biological questions.

Developers would also have to address packaging, power, heat, sterilization, mechanical fatigue and the stability of every interface over the proposed operating life. For an implanted product, failures that interrupt sensing or stimulation have different consequences from failures in a temporary laboratory patch.

The International Medical Device Regulators Forum published a final 2024 edition of its common principles for medical-device safety and performance. National and regional authorities apply their own legal pathways, so authorization in one market would not establish availability elsewhere.

Neither research paper reports a long-term human clinical trial of an implanted product using its platform. APPI News could not verify a marketed implant using either 2026 platform at the time of writing.

Frequently asked questions

Are liquid-metal circuits the same as conventional flexible circuit boards?
No. Conventional flexible circuits are designed to bend, while the material in the 2026 study was engineered to preserve connected conductive paths as the polymer stretched. The paper tested a new fabrication method and material structure, not a replacement circuit board ready for every device.

Did the stretchable computing array diagnose heart disease?
No. It ran pre-trained calculations on stored health data. The reported 99.6 percent figure concerned the location of electrical wavefronts in donor-heart mapping data, not diagnosis in a clinical trial.

Can either platform be implanted now?
The papers do not establish that. They report materials, circuits and prototype demonstrations. A finished implant would require device-level reliability, biological-safety and clinical evidence, followed by authorization in each market where it would be sold.

Review finds AI speeds credible-looking health misinformation

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

A systematic review published on January 29, 2026, found that generative AI increased the volume, speed and perceived credibility of health misinformation in the available research. The BMC Public Health review included 15 empirical studies published between January 2023 and August 2025 and found that people often struggled to distinguish AI-generated health misinformation from human-written material.

The finding complicates the case for clinicians using AI to produce public-facing posts, videos and graphics. The tools can turn source material into a draft quickly, but a professional remains responsible for checking what the draft says, what it leaves out and whether the evidence applies to the audience described.

Health professionals have a role beyond the clinic

Social platforms allow health professionals to explain evidence directly to a large audience, without waiting for a consultation or a traditional media interview. The World Health Organization (WHO) has treated that channel as part of public-health communication. A WHO-hosted 2021 toolkit described doctors and nurses as effective, trusted messengers and set out ways for them to create, reuse or share reliable vaccine information during the COVID-19 pandemic.

That toolkit addressed a specific emergency and vaccine campaign, not every health topic or platform. Its premise remains useful: a medical qualification can give a post authority, but the published claim still needs a traceable source and an honest account of uncertainty.

A broader evidence review shows why the task is difficult. A 2024 Journal of Medical Internet Research review synthesized 70 English-language sources published from January 2012 through March 2024 and found broad agreement that health misinformation on social platforms is a problem. The authors said health professionals were well placed to respond, but workload and stress limited their ability to do so.

AI changes production time, not the evidence threshold

Generative AI can draft text, summarize documents and propose visual or video structures. That makes it useful for moving from a blank page to material a clinician can edit. It does not show whether a paper is current, whether a numerical result applies outside the study population or whether a statement has crossed from education into an unsupported treatment claim.

WHO's 2024 guidance on large multi-modal models says health-focused systems can produce false, inaccurate, biased or incomplete statements and may encourage automation bias. The guidance calls for defined tasks, stakeholder involvement, post-release auditing and independent assessment. Those controls matter before publication because fluent wording can conceal a missing source or an overstated conclusion.

A workable editorial process separates machine assistance from professional approval. AI may organize questions, compare a draft with supplied sources or convert an approved outline into several formats. The human publisher still needs to open the original source, confirm every number and date, preserve limits stated by the researchers and remove any citation that cannot be found.

Short posts still need context

Platform formats reward compression, while medical evidence often depends on population, comparator, outcome and time period. Removing those conditions can turn an accurate study result into a misleading general claim. A post should therefore identify the institution or paper behind a claim and state whether the finding comes from a trial, an observational study, a review or public guidance.

Updates also need a process. Guidance changes, studies are corrected and regulatory decisions differ across countries. A creator who cannot revise an old graphic or attach a correction risks leaving a widely shared claim online after its evidence has changed.

The 2026 generative-AI review also limits how far its own conclusions can travel. Its authors called for more real-world testing across languages, platforms and formats, especially audio and video. The available evidence supports caution about scale and credibility; it does not measure the accuracy of every model or every clinician-led account.

Professional authority can magnify commercial claims

Clinical credentials may make product endorsements or treatment claims more persuasive. The World Medical Association's October 2024 guidance says physicians appearing in mass media should provide objective, evidence-based information, avoid unproven procedures or products and include material risks when discussing interventions. It also says physicians should not use media appearances to recommend named products or exaggerate their qualifications for commercial benefit.

That professional guidance is international, but it is not a substitute for national law. Rules governing health advertising, patient confidentiality, professional titles, sponsorship disclosures and remote interactions differ by country. The source article cited Taiwan's rules for medical institutions and personnel; those rules cannot be presented as a global legal standard.

Trust depends on a visible verification chain

Follower counts and posting frequency do not measure accuracy. Readers can inspect a stronger set of signals: whether claims link to identifiable evidence, whether credentials and financial relationships are disclosed, whether uncertainty is stated and whether corrections remain visible.

For clinicians, AI can reduce the labor of producing a draft, but it also makes unsupported material easier to publish at scale. The defensible division of work is narrow: machines can assist with production, while people remain accountable for evidence, context, privacy and the final decision to publish.

Freeze-dried platelet injections lack robust pain evidence

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

A 2026 laboratory study found that freeze-dried platelet-rich plasma could be rehydrated after storage, but it did not test pain relief or tissue repair in patients. Published human evidence for the freeze-dried product remains too limited to borrow treatment claims from conventional platelet-rich plasma.

The product is sometimes called platelet-lyophilized treatment (PLT) in Taiwan. It is made from a patient's blood: platelet-rich plasma is separated, freeze-dried for storage and later reconstituted. The process differs from conventional platelet-rich plasma (PRP), which is generally prepared and used fresh.

The latest study measured storage, not treatment

The 2026 study used PRP from 15 healthy donors to compare conventional freeze-drying with spray freeze-drying at room temperature, 4 degrees Celsius and minus 80 degrees Celsius. Researchers examined the dried material after 42 days and 12 months and measured several growth factors after rehydration.

Those endpoints can show whether processing and storage alter a blood product. They do not show whether an injection reduces pain, restores function or repairs a tendon, ligament, nerve or joint.

When symptoms after an injection need urgent assessment

Any injection into or near a joint can be followed by a serious infection, even though the risk is uncommon. The United Kingdom's National Health Service advises urgent assessment for sudden severe pain in one joint, swelling, skin-color change, fever or feeling hot, cold or shivery. Symptoms that develop quickly over a few days should not be assumed to be a normal treatment reaction.

Freeze-drying may improve storage, but evidence is sparse

A 2020 systematic search identified 46 experimental or clinical papers on freeze-dried PRP or platelet-rich fibrin. Most work involved cells, animals, preservation methods or biomaterials. Among the musculoskeletal studies, the review listed one preliminary human study of an injection for osteoarthritis; the remaining entries were laboratory or animal experiments.

The review found that some freeze-dried preparations retained platelet function or measured growth factors during storage. It also identified unresolved questions about standardizing preparation, biological activity, sterility and national regulatory requirements. Different products may preserve intact platelets, platelet lysates or released proteins, so the label does not describe one uniform intervention.

A later human study remained small and addressed a different use. A 2021 pilot combined freeze-dried PRP with synthetic graft material during dental sinus-floor surgery in five patients. It had no control group, and its authors said further studies were needed before drawing conclusions about efficacy. That study cannot establish an effect on musculoskeletal pain.

PRP findings do not establish PLT efficacy

Conventional PRP has a larger clinical literature, but the results apply to particular preparations, injuries and procedures. A 2020 meta-analysis pooled seven randomized trials with 541 patients who received conventional PRP during arthroscopic rotator cuff repair. It reported a lower retear risk and small improvements in some short-term scores.

That evidence concerns PRP placed at the bone-tendon interface during surgery. It does not test freeze-dried PLT injections for chronic nerve pain, nonsurgical sports injuries or general joint maintenance. Processing can change the composition and release of biological signals, and a plausible mechanism is not proof of the same clinical outcome.

Guidelines also describe uncertainty even for conventional PRP. The United Kingdom's National Institute for Health and Care Excellence says evidence on PRP efficacy for knee osteoarthritis is limited in quality. Its guidance calls for special clinical-governance, consent and audit or research arrangements, along with randomized trials and medium- to long-term follow-up.

The available evidence leaves major groups untested

The published freeze-dried PRP literature does not establish safety or benefit for children or pregnant people with musculoskeletal pain. It also does not provide a general protocol for people with blood disorders, autoimmune disease, diabetes or long-term medication use. People in these groups should discuss an injection with a clinician who can review the diagnosis, medicines, bleeding risk and local product status.

Imaging or an injection should not replace diagnosis of unexplained swelling, a mass or new loss of function. A clinician must first identify the condition being treated and consider established options, including rehabilitation or surgery where appropriate.

What patients can ask before considering the procedure

A clinic should be able to identify the exact preparation, whether it contains intact platelets or a lysate, how it was processed and stored, and what clinical evidence supports the proposed use. Evidence from fresh PRP should be labeled as indirect when the offered product is freeze-dried.

Patients can also ask what other treatments were considered, what outcome would count as success, how adverse events are monitored and what the full cost covers. Availability, authorization and reimbursement vary by country; APPI News did not verify those questions market by market.

APPI News could not find a published randomized trial of freeze-dried PRP injections for musculoskeletal pain at the time of writing. The existing evidence supports continued research into storage and standardization, not broad claims that PLT relieves chronic pain or repairs sports and degenerative injuries.

Breastfeeding pressure linked to anxiety as partners share care

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

A 2024 longitudinal study of 225 postpartum parents in New Zealand linked strong pressure to breastfeed with higher anxiety, stress and birth-trauma symptoms four weeks later. A separate review of partner support found generally favorable associations with breastfeeding outcomes, but the evidence base was small and did not establish that any household task would extend breastfeeding for an individual family.

The findings shift attention from monitoring milk volume to the conditions around feeding. Practical help with household work and childcare can reduce the number of tasks carried by the breastfeeding parent, while feeding pain, concerns about milk transfer and mental-health symptoms remain matters for trained health workers.

Some postpartum mental-health signs need urgent care

Thoughts of suicide, self-harm or harming the baby require urgent help through local emergency or crisis services. The United Kingdom's National Health Service (NHS) lists these thoughts among symptoms of postnatal depression and says persistent or worsening low mood, anxiety, irritability or difficulty coping should prompt clinical help.

Hallucinations, delusions, severe confusion, unusually elevated or overactive behavior, and rapidly changing moods soon after birth require an urgent assessment. The NHS describes postpartum psychosis as a medical emergency that often begins suddenly in the first two weeks after birth and can worsen rapidly. A partner or relative may need to seek help because the affected person may not recognize the change.

Emergency numbers and access routes differ by country. If there is immediate danger, family members should contact the local emergency service and give responders specific information about the recent birth, behavior changes and any expressed intent to cause harm.

Breastfeeding pressure was associated with later distress

The 2024 Frontiers in Public Health study used two online surveys, about four weeks apart, to examine feeding experiences and mental-health symptoms among 225 postpartum mothers and other birthing parents living in New Zealand. At the first survey, 39.6 percent reported strong pressure to breastfeed, 17.8 percent reported shame about feeding choices and 51.6 percent reported feeding-related stress.

Strong pressure in the first survey was associated with higher anxiety, stress and birth-trauma symptom scores at follow-up. The later associations with depression and suicidal thoughts were not statistically supported. Participants volunteered for the study and reported their own symptoms, so the results do not prove that pressure caused the later distress or predict outcomes in other countries.

Responses described pressure tied to social expectations, limited autonomy and the belief that breastfeeding performance reflected success as a parent. Repeated questions about whether there is “enough” milk may reinforce that pressure when they are framed as an assessment rather than a request for information about a clinical concern.

Partner evidence favors practical and responsive help

A 2020 systematic review screened 697 records and retained seven studies that assessed specific forms of partner support and breastfeeding initiation, duration or exclusivity. Four studies associated verbal encouragement with longer duration or greater exclusivity. Other favorable findings involved responsiveness to the parent's needs, help with feeding difficulties, and household or childcare work.

The review did not support a universal checklist. Only two included studies were controlled clinical trials; the remainder used prospective, cross-sectional or qualitative designs. The authors reported a lack of high-quality population evidence, which means the findings identify plausible forms of support rather than promise a feeding outcome.

Partners can take ownership of meals, laundry, diaper changes, burping, settling the baby, washing feeding equipment when it is used, managing visitors and caring for other children. The useful split depends on the parent's recovery, the infant's needs, the feeding method, available leave, disability and household structure. Asking which task needs to be taken over leaves the feeding parent in control of the decision.

WHO guidance puts support within postnatal care

The World Health Organization's 2022 postnatal guideline defines a positive experience as one in which women, newborns, partners, parents, caregivers and families receive consistent information, reassurance and support from health workers. Its recommendations include partner involvement, breastfeeding counselling, and screening for maternal depression and anxiety where assessment, referral and management services are available.

Household support and clinical care serve different functions. A trained health worker should assess persistent feeding pain, concerns about attachment or milk transfer, or an infant who may not be feeding effectively. A partner can arrange transport, attend an appointment if invited, record questions and continue household work without diagnosing the problem or setting a feeding target.

Preterm or unwell infants may need an individual feeding plan from their clinical team. Parents who are pregnant, have a chronic condition or take regular medicine should also seek advice matched to their circumstances before changing medicine, supplements or feeding practices.

Support can continue if the feeding plan changes

Breastfeeding, expressed milk, combination feeding and formula place different demands on a household. Practical support can continue across those changes. A feeding decision does not remove the need for meals, rest, childcare, clean equipment where relevant and access to postnatal care.

Relatives and friends can contribute by accepting defined tasks and respecting the parents' decisions. Advice or comparisons that were not requested can add another layer of negotiation. A concrete offer to prepare food, wash dishes or handle laundry gives the parent a choice without making feeding performance the condition for support.

APPI News has a separate guide to how partners, relatives and health workers can divide support while protecting the parent's feeding choices. The central limit in both sets of evidence is the same: partner involvement is associated with better outcomes in some studies, but it cannot guarantee breastfeeding duration or replace professional assessment.

Weak randomness can quietly weaken health data access controls

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

A July 30, 2026 security advisory from hardware-wallet maker Coinkite exposed a failure pattern that also deserves attention in health information systems: a security-sensitive random value can have the right format while lacking the expected unpredictability. Coinkite said corrected firmware protects future seed generation but cannot change or repair seeds created by affected firmware.

The incident does not establish that hospital systems contain the same defect. It shows why teams cannot treat a successful function call as proof that a pseudonym, research identifier or authorization secret came from the intended random-number generator. The technical root cause and affected Coldcard releases are covered in APPI News' analysis of the firmware failure.

Valid output can conceal a security failure

Ordinary functional tests confirm that an identifier has the required length, an authorization request completes or a token can be redeemed. Those checks do not measure how difficult the value is to predict. A weak generator can therefore supply syntactically valid output while reducing the number of possibilities an attacker must examine.

The damage may also survive the software fix. New code can change the generator used from that point forward, but it does not retroactively change pseudonyms already distributed in research datasets or secrets used in completed authorization flows. Incident response must identify which outputs were created by the affected path, where they traveled and whether they can be replaced or revoked.

Checkpoint one: pseudonyms are only one part of de-identification

Pseudonymization replaces a direct identifier with another value so records can be linked without displaying the person's name or other direct identifier. If a system relies on that replacement value being hard to guess, a predictable generator weakens the control and may make linkage attacks easier. The actual exposure depends on the generator, the mapping table, other fields in the dataset and who can obtain the records.

Random identifiers are not a complete de-identification method. The US National Institute of Standards and Technology's SP 800-188 says that tools which merely mask personal information may not provide sufficient de-identification, and recommends measurable performance standards and re-identification studies. A review should therefore test the dataset's disclosure risk as well as the code that creates its pseudonyms.

This distinction prevents two opposite errors. A team should not assume that a random-looking subject ID makes a dataset safe, but it should not claim that one weak identifier automatically reveals every person either. De-identification remains a governed process involving data transformation, access conditions and an explicit assessment of re-identification risk.

Checkpoint two: SMART authorization depends on a secret verifier

Fast Healthcare Interoperability Resources (FHIR) is HL7 International's standard for exchanging health information. SMART App Launch adds an OAuth 2.0 authorization framework that allows apps to request defined access to FHIR data. Version 2.2.0 requires all SMART apps to support Proof Key for Code Exchange (PKCE), while SMART servers must support the S256 challenge method and must not support the plain method.

For each authorization request, the app creates a secret code_verifier and sends a SHA-256-derived code_challenge. It later presents the original verifier when exchanging the authorization code for an access token. IETF RFC 7636 defines the verifier as a high-entropy cryptographic random string, recommends generating a 32-octet random sequence and states that an intercepted authorization code cannot be redeemed without the verifier.

A low-entropy verifier can narrow the guesses available to an attacker under the attack conditions described by the RFC. The protocol can still appear to work because the server checks whether the submitted verifier matches the earlier challenge, not whether the app's generator had the expected entropy. That conclusion is an engineering inference from the protocol, not a report of a verified breach in a SMART deployment.

Checkpoint three: test the source, path and finished build

Randomness assurance has several separate parts. An entropy source needs tests that can detect failures in its underlying noise process, while the application needs integration tests proving that the production call reaches the approved random-bit generator. Release review must also cover build flags, linked components and fallback behavior because source code can contain the right implementation without selecting it in the finished artifact.

NIST SP 800-90B specifies design and validation requirements for entropy sources and requires both startup and continuous health tests. Startup tests examine the noise source before output is released. Continuous tests look for failures while the source operates, although the standard cautions that resource limits mean such tests are generally aimed at gross failures rather than every possible weakness.

Those health tests do not replace build and integration checks. A practical review should fail closed when the intended cryptographic generator is unavailable, identify which implementation serves security-sensitive calls and exercise that path in the production configuration. This three-part structure is a system-design inference from the NIST requirements and the Coldcard failure, not a claim that SP 800-90B prescribes a health-sector checklist.

Past outputs need their own incident scope

When a random-number defect is confirmed, replacing the generator addresses only new output. Teams must separately inventory pseudonyms, research subject IDs, client secrets, reset links, nonces and other values created during the affected period. Each type of output has a different response: some can be rotated or revoked, while distributed research identifiers may require notification, access review or a new data release.

The priority is evidence about the deployed path. Statistical analysis of samples can reveal some failures, but clean-looking samples cannot prove that an attacker lacks a predictor or that the application called the intended implementation. Configuration review, dependency tracing, runtime health signals and records showing when each output was generated provide different pieces of the incident timeline.

Frequently asked questions

Does a weak random number generator make every de-identified dataset identifiable?
No. It can weaken a pseudonym that depends on unpredictability, but re-identification risk also depends on the remaining fields, the linking key, access controls and the data-release model.

Why can PKCE still complete when its verifier is weak?
The server verifies the mathematical relationship between the verifier and challenge. It does not measure how the client generated the verifier, so a predictable value can pass the protocol's normal equality check.

Can output statistics prove that a generator is secure?
No. Statistical and health tests can detect defined failure patterns, but assurance also depends on the entropy-source design, its validation and proof that the deployed application uses the intended generator.

What should a system owner check first?
Identify every security-sensitive value produced by randomness, trace each production call to its generator, review fallback behavior and determine whether past outputs can be rotated, revoked or reissued.

Hot weather makes the two-hour food safety rule harder to meet

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

The World Health Organization (WHO) estimated in June 2026 that unsafe food causes about 866 million illnesses and 1.5 million deaths annually. The estimate covers biological and chemical hazards, while the household controls discussed here address the growth and transfer of disease-causing microorganisms.

Warm conditions reduce the time available to cool, serve or store perishable food safely. The practical decision is based on measured temperature and elapsed time, not whether a dish still looks or smells normal.

Warning signs require prompt medical assessment

Bloody diarrhea, diarrhea lasting more than three days, fever above 39°C, or vomiting so frequent that liquids will not stay down call for prompt medical assessment. So do signs of dehydration, including very little urination, a dry mouth or throat, or dizziness on standing. The US Centers for Disease Control and Prevention lists these as signs of severe food poisoning.

The US CDC identifies children under five, pregnant people, adults aged 65 and older, and people with weakened immune systems as groups at higher risk of severe foodborne illness. Children can lose fluid quickly, and pregnant people with fever and flu-like symptoms should contact a clinician. People in these higher-risk groups, those with chronic illness and anyone taking regular medicines should seek individual advice rather than applying general adult self-care guidance.

A related APPI News guide gives a fuller account of dehydration, bloody diarrhea and other warning signs after suspected food poisoning.

The global rule uses cold, hot and time controls

WHO advises keeping refrigerators below 5°C, holding cooked food above 60°C and leaving cooked food at room temperature for no more than two hours. Chilling slows microbial growth but does not stop it, so refrigeration does not provide indefinite storage.

The interval between cold and hot holding is often called the temperature danger zone. The phrase is useful, but the exact lower boundary differs between authorities: WHO uses below 5°C as its preferred refrigeration target, while United States consumer guidance uses 4°C or below. A single universal range would conceal that difference.

Bacterial growth can accelerate under favorable conditions, but the rate is not fixed. It depends on the organism, food, moisture, acidity, starting contamination and temperature. The two-hour limit is therefore a public-health control point, not a calculation showing that every bacterial population grows at the same rate.

Heat can shorten the time available

WHO says hot and humid weather improves the conditions in which germs multiply and warns that contaminated food may not look, taste or smell different. That makes outdoor meals, food carried in vehicles and dishes left on a serving table harder to control during hot weather.

FoodSafety.gov, the United States government food-safety portal, says perishable food should be refrigerated within two hours, or within one hour when it is exposed to temperatures above 32°C. That one-hour threshold is US guidance rather than a worldwide standard. Local public-health instructions take priority when they are more restrictive.

A hot room is not the only concern. A parked car, picnic table in direct sunlight or crowded buffet can expose food to temperatures above the reported air temperature. Cold dishes need ice or refrigeration, while hot dishes need equipment that can hold them above 60°C rather than merely keep them warm.

Cooling starts with smaller portions

Prompt refrigeration matters most for cooked food that will be kept. Large pots and deep containers cool slowly at the center, even after they enter a refrigerator. Dividing food into shallow containers increases the surface area and allows heat to leave more quickly.

United States guidance sets household refrigerators at 4°C or below and freezers at -18°C or below. WHO recommends refrigeration below 5°C. An appliance thermometer can reveal whether a refrigerator reaches the selected target, especially when it is full or opened frequently.

Freezing pauses growth but does not reliably destroy harmful germs. Food still needs safe thawing and preparation after it leaves the freezer. WHO advises thawing in a refrigerator, cold water or a microwave instead of on a counter at room temperature.

Reheating cannot correct every earlier failure

Thorough cooking kills almost all dangerous microorganisms, and WHO uses at least 70°C as a general benchmark for foods such as soups, stews, meat and poultry. Reheating leftovers until steaming hot can reduce hazards from live organisms, but it does not establish that food mishandled earlier is safe.

WHO describes cereulide, a toxin produced by some strains of Bacillus cereus, as stable at temperatures up to 121°C. There is no household test that can reconstruct an unknown time-and-temperature history. Perishable food that has exceeded the applicable room-temperature limit should be discarded rather than sampled or reheated as a safety test.

Temperature control is only one layer

Food can acquire microorganisms from hands, cutting boards, utensils, raw meat, seafood, eggs, water or other ingredients. WHO's five basic controls are to keep clean, separate raw and cooked food, cook thoroughly, keep food at safe temperatures, and use safe water and raw materials.

Raw food should be stored in sealed containers away from ready-to-eat dishes. Separate utensils or thorough washing between tasks reduces cross-contamination, while covering prepared food protects it during serving and storage.

Time and temperature provide usable limits, but they cannot prove that a meal is safe. When the storage history is unknown, when refrigeration failed, or when a perishable dish has remained outside the applicable limit, discarding it avoids relying on smell, appearance or a final round of heating.

WHO’s five food safety steps reduce risks in summer kitchens

APPI News Editorial — Wed, 05 Aug 2026 00:00:00 GMT

The World Health Organization (WHO) organizes household food safety around five actions: keep clean, separate raw and cooked food, cook thoroughly, keep food at safe temperatures, and use safe water and raw materials. The framework applies to consumers and food handlers worldwide rather than to one cuisine or health system.

Heat and humidity create better conditions for germs to multiply, while contaminated food may still look, taste and smell normal. A household defense therefore has to control how food is handled and stored from purchase through serving.

Severe symptoms require prompt medical assessment

The US Centers for Disease Control and Prevention (CDC) advises seeking medical help for bloody diarrhea, diarrhea lasting more than three days, fever above 39°C, repeated vomiting that prevents fluid intake, or signs of dehydration. Very little urination, a dry mouth or throat, and dizziness on standing are listed dehydration warnings. Difficulty swallowing, muscle weakness, blurred or double vision, drooping eyelids or slurred speech also require urgent assessment rather than home observation.

Children who cannot drink, urinate much less than usual or become unusually drowsy need prompt clinical assessment. Pregnant people should contact a clinician if fever occurs with flu-like symptoms. People with chronic illness, weakened immunity or regular medicines should ask a clinician how dehydration or infection may affect their condition and treatment.

A separate APPI News report explains dehydration, bloody diarrhea and other warning signs after suspected food poisoning. Symptoms alone cannot identify the food or microorganism responsible.

Clean hands and equipment before contamination spreads

The first WHO step covers hands, cloths, cutting boards, utensils and preparation surfaces. Washing before touching food and during preparation interrupts one route by which microorganisms reach ready-to-eat dishes.

The CDC tells US households to wash hands with soap and water for at least 20 seconds before, during and after food preparation, and to wash utensils, boards and counters with hot, soapy water after each food item. Fresh fruit and vegetables should be rinsed under running water. Gloves do not replace handwashing because contaminated gloves can transfer germs between the same surfaces.

Separate raw food from meals ready to eat

Raw meat, poultry, seafood and eggs can carry microorganisms in their juices. Separation needs to continue in shopping bags, the refrigerator and the preparation area, not begin only when cooking starts.

Sealed containers prevent raw juices from dripping onto produce or cooked food. Separate cutting boards and plates are useful, but equipment can also be washed thoroughly with hot, soapy water before it is used for another task. A plate or pair of tongs that held raw meat should not be reused for cooked food without washing.

Use temperature, not color, to check cooking

WHO’s summer food safety guidance says cooking food to at least 70°C reduces risk and recommends bringing soups and stews to a boil. A clean food thermometer provides more information than surface color or cooking time alone because the coolest point may be inside the thickest part of a dish.

The 70°C figure is a broad WHO benchmark, not a complete table for every food. National authorities may specify different minimum internal temperatures and holding times for poultry, ground meat, seafood or reheated food. Package directions and the applicable national food-safety authority should govern when they set a more specific rule.

Control both storage temperature and elapsed time

WHO advises leaving cooked food at room temperature for no more than two hours, refrigerating cooked and perishable food promptly below 5°C, and holding cooked food above 60°C before serving. Cold storage slows microbial growth but does not stop it indefinitely.

The clock starts when a perishable dish leaves controlled cold or hot storage. A lunch carried without cooling, food left in a hot vehicle and dishes kept on an outdoor table may warm faster than food in an air-conditioned room. When the storage history is unknown or a perishable dish exceeds the applicable limit, smell and appearance cannot restore confidence in its safety.

Large batches cool more slowly at the center than small portions. Dividing leftovers among clean, shallow containers before prompt refrigeration helps heat escape. Frozen food should thaw in a refrigerator, cold water or a microwave rather than on a counter at room temperature.

Safe water and ingredients complete the five-step defense

Water and ice can carry microorganisms or chemicals, so the final WHO step starts with a supply known to be safe. Produce eaten raw should be washed with safe water, and damaged, moldy or expired ingredients should not be treated as usable simply because they will later be chilled or cooked.

Pasteurization and other validated processing steps reduce hazards in products such as milk. Labels also provide storage and use-by instructions that a household checklist cannot replace. A power outage, broken refrigerator or product recall changes the decision even when the meal was prepared correctly.

Higher-risk groups need stricter food choices

The CDC identifies children under five, pregnant people, adults aged 65 and older, and people with weakened immune systems as more likely to become seriously ill from contaminated food. The agency includes some people with diabetes, liver or kidney disease and those receiving chemotherapy or radiation among those whose immune defenses may be weaker.

Young children should receive age-specific food and hydration advice rather than adult instructions. Pregnant people need pregnancy-specific advice because some infections can harm a pregnancy even when the parent’s illness appears mild. Older adults, people with chronic disease, those with weakened immunity and people taking regular medicines should use guidance from their own national health authority or clinician for food choices and early care.

A five-point check follows the food from purchase to storage

A practical check asks whether hands and equipment are clean, raw food is contained, the center of the food reached the applicable temperature, and perishable food stayed within its time and temperature limit. It also asks whether the water, ice and ingredients came from a safe source and remain within their labeled storage period.

No single step compensates for all failures in the others. Thorough reheating cannot prove that a dish mishandled earlier is safe, and refrigeration cannot undo cross-contamination. The related APPI News report on hot weather and the two-hour food safety rule examines the time-and-temperature layer in more detail.